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To detect pathogen attack and subsequently trigger defense responses, plants 
utilize immune receptors composed of a nucleotide binding site (NB) domain and a 
C-terminal leucine-rich repeat (LRR) domain. Proper regulations of NB-LRR protein 
stability and activity are critical for plant healthy. Three genes, RAR1, SGT1 and 
HSP90, were uncovered as key regulators of NB-LRR proteins. To further study the 
mechanism that regulates NB-LRRs, I performed a genetic screen in the model plant 
Arabidopsis thaliana to isolate rar1 suppressor (rsp) mutants which restore the loss 
of NB-LRR protein accumulation, and the consequent loss of NB-LRR function, that 
are the principal phenotypes of rar1 mutants. Here, I present two rsp alleles of 
hsp90.2 mutants identified in the rar1 suppressor screen. The hsp90.2rsp mutants 
suppress all known rar1 phenotypes including reduced NB-LRR protein 
accumulation and loss of NB-LRR-mediated resistance to pathogens. The positions 
of hsp90.2rsp mutations in HSP90 crystal structure suggest that RAR1 likely functions 
in destabilizing the lid-closed conformation of HSP90, and induce the lid- open 
conformation that is important for loading and/or affecting NB-LRR clients. In 
addition, I describe two rsp alleles of COI1 gene which encodes a well-
 iii 
characterized receptor of the phytohormone Jasmonic Acid (JA). It is widely 
accepted that COI1 is involved in JA signaling-dependent disease resistance. 
However, the new coi1rsp mutants affected NB-LRR accumulation in a pattern 
independent of the JA signaling pathway. This indicates that not all disease 
resistance effects of COI1 require JA signaling. Moreover, I observed the genetic 
interactions between COI1 and two NB-LRR regulators, SGT1b and HSP90. coi1rsp 
proteins are expected to regulate NB-LRR accumulation levels and function via 
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This chapter provides an introduction of background knowledge for the contribution 
of the subsequent chapters to the field of plant disease resistance. Some contents of 
this chapter repeatedly appear as introductory sections in the subsequent chapters.  
INTRODUCTION  
During their life cycle, plants have to fight various pathogens including fungi, bacteria, 
viruses, and nematodes. Unlike animals, plants lack specialized mobile immune 
cells that exclusively fight pathogens. To protect themselves, plants must rely on the 
innate immune system of each plant cell to detect pathogen attack and subsequently 
activate resistance responses. It is known that the plant immune system is made up 
of two related branches (Dodds et al. 2010, Jones et al. 2006, Maekawa et al. 2011).  
PAMPs recognition and PTI 
The first branch utilizes pattern recognition receptors (PRRs) to identify pathogen 
marker molecules that are termed pathogen- or microbial-associated molecular 
patterns (PAMPs or MAMPs; hereafter referred to as PAMPs). PAMPs are highly 
conserved pathogen components that are necessary for pathogen survival and/or 
virulence. For example, flagellin, a model PAMP, provides flagellum-based mobility 
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to bacteria, and hence plays a critical role in bacterial pathogenicity (Zipfel et al. 
2005). As the PAMPs are indispensible for pathogens, PAMPs are recognized by 
the plant immune system as warning signs of the presence of potential pathogens. 
This recognition is mediated by the extracellular leucine-rich repeat (LRR) domain of 
PRRs, and then initiates PAMP-triggered immunity (PTI) (Dodds et al. 2010, Jones 
et al. 2006, Maekawa et al. 2011). PTI can restrict further colonization of pathogens 
with multiple responses including the production of ion flux and callose deposition, a 
physical barrier at infection sites (Gómez-Gómez 2004). 
Successful pathogens overcome PTI 
Even though plants establish a defense based on perception of PAMPs, pathogens 
are still able to evade or suppress PTI with their virulence factors. For example, plant 
pathogenic bacteria inject ~30 effector proteins per strain into plant cells using a 
evolutionarily conserved type III secretion system (TTSS) (Grant et al. 2006). Type 
III effectors contribute to pathogen virulence by interfering with various plant 
defense-related cellular processes. One common set of targets of TTSS effectors 
are phytohormone signaling processes which play critical roles in integrating plant 
defense responses with normal cellular functions (Fig. 1.1). A growing body of 
literature demonstrates that some effectors are able to hijack various phytohormone 
signaling pathways to help pathogens to colonize host cells (Cunnac et al. 2009, 
Grant et al. 2006, Mudgett 2005). For example, the Pseudomonas syringae specific 
HopI1 effector contributes to virulence on Arabidopsis and tobacco. In host cells, 
HopI1 is localized to chloroplasts and suppresses the accumulation of chloroplast-
synthesized salicylic acid (SA). Due to the necessity of SA for resistance against 
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biotrophic pathogens, HopI1-mediated reduction of SA accumulation impairs 
defense responses against P. syringae in host plants (Jelenska et al. 2007). AvrPtoB, 
another P. syringae effector, can increase host abscisic acid (ABA) levels, leading to 
the attenuation of callose deposition which is a marker response for PTI (de Torres-
Zabala et al. 2007). Ethylene (ET) is another phytohormone known to regulate 
defense responses. It is reported that ET signaling is also affected by type III 
effectors. At least five effectors, AvrB, AvrRpt2, AvrPphB, HopK1, and AvrPphEpto, 
can induce the expression of RAP2.6, an ET response factor gene associated with 
disease susceptibility (He et al. 2004).  
 
Figure 1.1. Crosstalk between P. syringae effectors and plant phytohormone signaling 
network.  
SA: salicylic acid; GA: gibberellic acid; BL: brassinolides; ABA: abscisic acid; JA: jasmonic 
acid; ET: ethylene; COR: Coronatine; ⊥, negative effect; arrow, positive effect. This figure is 
drawn, with some changes, after the figures in references (Pieterse et al. 2009, Robert-
Seilaniantz et al. 2007). 
4 
 
The phytohormone signaling network is a complicated system constituted of different 
signaling pathways (Bari et al. 2009). These pathways affect each other by an 
intricate set of synergistic and/or antagonistic interactions called signaling crosstalk. 
Signaling crosstalk is also exploited by type III effectors to help pathogen growth in 
host cells (Fig. 1.1). A well characterized crosstalk targeted by this strategy is that 
between SA and JA (Jasmonic Acid). Plants are subject to attack by two classes of 
pathogens: biotrophic and necrotrophic (Dangl et al. 2001). Biotrophs grow in and 
obtain nutrition from living cells. By contrast, necrotrophs kill host plant cells first, 
and feed on dead or dying cells. To adapt to different conditions and growth stages, 
quite a few pathogens deploy both biotrophic and necrotrophic phases during their 
life cycle. Such pathogens are termed hemi-biotrophs (Glazebrook 2005). For 
Arabidopsis, the oomycete pathogen Hyaloperonospora arabidopsidis (Hpa) is a 
typical biotroph. From germination of conidia on the leaf surface to the formation of 
oospores and mature conidia, the infected plant cells remain alive throughout the life 
cycle of Hpa (Koch et al. 1990). Two fungal pathogens, Borytis cinerea and 
Alternaria brassicicola, are examples of Arabidopsis necrotrophs. Host cells are 
killed by these two fungi soon after infection (Colmenares et al. 2002, Thomma et al. 
1998). Pathogenic bacteria P. syringae, including the model strain Pto DC3000, 
require living host cells at the early stages of infection, but kill host tissues as 
evidenced by chlorosis and necrosis at the late stage of infection. Hence, P. 
syringae is considered an Arabidopsis hemi-biotroph (Glazebrook 2005, Thaler et al. 
2004). To react against pathogen infection, plants activate a series of signaling 
pathways, including SA and JA signaling pathways, to enhance disease resistance 
5 
 
(Fig. 1.1). It has been generally accepted that SA and JA signaling play important 
roles in the induction of resistance responses against biotrophs and necrotrophs, 
respectively (Bari et al. 2009).  
Most of the crosstalk between SA and JA consists of mutual antagonism (Bari et al. 
2009). This concept is supported by genetic studies with Arabidopsis mutants. Two 
SA signaling deficient mutants, enhanced disease susceptibility 4 (eds4) and 
phytoalexin deficient 4 (pad4), exhibit enhanced expression of PLANT DEFENSIN 
1.2 (PDF1.2) which is a reporter gene of JA signaling (Gupta et al. 2000). By 
contrast, three mutants with defects in JA signaling, the JA receptor coronatine 
insensitive 1 (coi1), mitogen activated protein kinase 4 (mpk4) and suppressor of SA 
insensitivity 2 (ssi2), display elevated SA accumulation and SA-induced 
PATHOGENESIS RELATED 1 (PR1) expression (Kachroo et al. 2001, Kloek et al. 
2001, Petersen et al. 2000). Elevated SA accumulation and PR1 expression are also 
detected in 12-Oxophytodienoate reductase 3 (opr3) and jasmonate resistant 1 (jar1) 
mutants which are impaired in the biosynthesis of JA and JA’s bioactive derivate JA-
isoleucine (JA-Ile) respectively (Makandar et al. 2010). The biological function of SA-
JA antagonism might be appropriate regulation of defense responses against 
pathogens. For example, SA-induced cell death can effectively limit the spread of 
hemi-biotrophs and biotrophs from infection sites. But cell death can also be a 
disadvantage for the defense against necrotrophs, which require dead plant cells for 
nutrients. Therefore, activating JA signaling and blocking SA signaling 
simultaneously is critical for defense responses against necrotrophs. On the other 
hand, SA-JA synergistic interactions are only beginning to be studied, e.g. 
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microarray assays demonstrate that some Arabidopsis defense-related genes are 
co-induced by SA and JA (Xu et al. 1994).  
P. syringae effectors function with the phytotoxin coronatine (COR) in activating JA 
signaling to suppress the SA signaling-dependent defense responses, contributing 
to plant susceptibility to bacterial pathogens (Zhao et al. 2003). The mechanistic 
contribution of COR to virulence will be further discussed later in this chapter.  
Other virulence functions of type III effectors include suppression of programmed 
cell death (PCD), suppression of plant cell wall remodeling, suppression of 
resistance protein activation (Mudgett 2005, Stavrinides et al. 2008). However the 
targets and specific functions of many effectors are still unclear. Furthermore, a 
recently published review noted that the distinction between PAMPs and effectors is 
not always clear (Thomma et al. 2011). Some PAMPs also contribute to pathogen 
virulence and display effector-like specificity in particular pathogen species, races, or 
strains, while some effectors are distributed widely, like PAMPs, across strains of 
various microbes. These examples imply that plants might not always engage their 
immune system in a strict PTI-ETI sequence.   
Plants use disease resistance (R) proteins to recognize virulence effectors, 
and activate disease resistance responses 
The type III effectors, required for virulence, can also be weaknesses to pathogens, 
as these effectors are also the targets for specific plant recognition of pathogens. 
This type of resistance, which results in effector-triggered immunity (ETI), is the 
second branch of the plant immune system (Dodds et al. 2010, Jones et al. 2006, 
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Maekawa et al. 2011). This ETI branch largely depends on the protein products of 
plant disease resistance (R) genes. R genes offer plants disease resistance by 
recognizing, directly or indirectly, specific type III effectors encoded by pathogens. 
Because its presence in a particular strain reduces pathogen virulence, a recognized 
effector protein is referred to as an avirulence (Avr) protein.  
The majority of R genes encode NB-LRR proteins containing a nucleotide binding 
site (NB) domain and a C-terminal leucine-rich repeat (LRR) domain. In mammals, 
NB-LRR containing (NLR) proteins, also termed NOD-like or Caterpillar proteins, 
mediate various processes in mammalian innate immunity (Ting et al. 2008). Plant 
NB-LRR proteins can be subdivided into two classes based on N-terminal structure. 
One class has a domain with homology to the intracellular signaling domains of the 
Drosophila Toll and mammalian interleukin-1 receptors (TIR); the other class has a 
putative coiled-coiled (CC) domain (Dangl et al. 2001). TIR- and CC-NB-LRR 
proteins require different functional regulators. TIR-mediated resistance responses 
depend on the EDS1 (ENHANCED DISEASE SUSCEPTIBILITY 1)/PAD4 
(PHYTOALEXIN DEFICIENT 4)/SAG101 (SENESENCE ASSOCIATED GNENE 101) 
complex, whereas CC-mediated responses rely on the NDR1 (NON-RACE-
SPECIFIC DISEASE RESISTANCE 1) protein (Aarts et al. 1998, Feys et al. 2005). 
Recognition of Avr effectors is the core step of NB-LRR-mediated ETI. It was 
expected that this recognition depends on a receptor-ligand like interaction between 
Avr protein and corresponding NB-LRR protein. However only three examples of 
direct Avr-NB-LRR interactions have been reported, and moreover, all three 
interactions were identified by yeast two-hybrid assays or in vitro protein binding 
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assays, not by in vivo assays (Deslandes et al. 2003, Dodds et al. 2006, Jia et al. 
2000). Currently, the “guard hypothesis” (Dangl et al. 2001) is applied to explain a 
second mechanism by which NB-LRRs recognize Avr effectors. This hypothesis 
suggests that Avr effectors mediate virulence functions by targeting and modifying 
specific host proteins. NB-LRRs, which “guard” these host targets, detect the 
modifications and activate a series of resistance responses. RIN4 (RPM1 
INTERACTING PROTEIN 4) is a well-characterized example of a host virulence 
target guarded by NB-LRRs. Four different Avr effectors, AvrRpm1, AvrB, AvrRpt2 
and HopF2Pto have been reported to target RIN4 (Axtell et al. 2003b, Mackey et al. 
2003, Mackey et al. 2002, Wilton et al. 2009). AvrRpm1, AvrB and AvrRpt2 
manipulate RIN4 resulting in increased phosphorylation (AvrB, AvrRPm1) or 
protease cleavage (AvrRpt2) (Axtell et al. 2003a, Chisholm et al. 2005, Coaker et al. 
2005, Kim et al. 2005, Mackey et al. 2002). These two manipulations are detected 
by the RPM1 and RPS2 NB-LRR proteins, respectively, and ETI is activated (Axtell 
et al. 2003b, Mackey et al. 2003, Mackey et al. 2002). In contrast, HopF2Pto targets 
RIN4, but does not induce ETI (Wilton et al. 2009).  
Thus, NB-LRR proteins recognize Avr effectors or their actions, and induce ETI, 
which is faster and stronger than PTI. ETI responses usually include cell wall 
strengthening, transcriptional reprogramming, and a form of programmed cell death 
termed hypersensitive response (HR) at the infection site (Dodds et al. 2010, Jones 
et al. 2006, Maekawa et al. 2011). Mis-activation of these strong responses can lead 
to inappropriate cell death and developmental arrest. For example, RPS2 is 
misactivated in rin4 mutants, causing seedling lethality. This lethality phenotype can 
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be suppressed by rps2 or rar1 mutations which completely or partially decrease 
RPS2 protein accumulation (Belkhadir et al. 2004, Mackey et al. 2003). The snc1 
mutant is another example where plant growth and development are impaired by 
mis-activation of NB-LRR proteins. In snc1 mutant plants, SNC1, which encodes a 
TIR-NB-LRR protein, is constitutively activated by a gain-of-function mutation. This 
auto-activation of SNC1 results in plant dwarfing, high accumulation of SA and 
constitutive expression of pathogenesis-related (PR) genes (Li et al. 2001). Two 
recently published papers noted that accumulation of SNC1 is negatively regulated 
by a TPR domain containing protein SUPPRESSOR OF rps4-RLD1 (SRFR1) (Kim 
et al. 2010, Li et al. 2010). The mutations of SRFR1 caused over-accumulation of 
SNC1, and thus led to stunted growth in the mutant plants. Similar to the rin4-rps2 
case, the stunting phenotype of the srfr1 mutants can be suppressed by snc1-r1 
which is a protein null allele of snc1. Hence, proper regulation of NB-LRR protein 
accumulation levels and pre-activation resting state are critical to the health of the 
plant cell.  
RAR1, SGT1b and HSP90 are required for NB-LRR stability and NB-LRR-
mediated resistance responses 
My dissertation research focuses on studying the mechanism that regulates stability 
and activity of NB-LRR proteins. Genetic analyses, especially mutant screens, 
uncovered three genes, RAR1 (REQUIRED FOR MLA12 RESISTANCE 1), SGT1 
(SUPPRESSOR OF THE G2 ALLELE OF SKP1), and HSP90 (HEAT SHOCK 
PROTEIN 90), as key regulators of NB-LRR stability and activity. Just as the 
structure of NB-LRR proteins is conserved from plants to animals, the regulation of 
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NB-LRR/NLR proteins is also conserved in both kingdoms. SGT1 and HSP90 have 
been demonstrated to be involved in regulation of both NB-LRR proteins in plants 
and NLR protein in animals (Ye et al. 2008). RAR1 only plays a role in plant immune 
systems (da Silva Correia et al. 2007).  
To identify new NB-LRR regulators, I performed a genetic screen in Arabidopsis to 
isolate rar1 suppressor mutants (Chapter 2 and 3). RAR1 was first identified in 
Hordeum vulgare (Barley) as required for resistance mediated by the R gene Mla12 
(Shirasu et al. 1999). However, most studies of RAR1 functions have been 
performed in Arabidopsis with many rar1 loss-of-function mutants isolated by three 
independent genetic screens (Muskett et al. 2002, Tornero et al. 2002, Warren et al. 
1999). Plants lacking RAR1 display a reduction in the resting steady state 
accumulation levels of all tested NB-LRR proteins (Belkhadir et al. 2004, Holt et al. 
2005, Tornero et al. 2002). However, RAR1 is not genetically required for the 
functions of all NB-LRRs. A threshold model has been invoked to explain the 
difference between the genetic and biochemical requirements for RAR1 (Bieri et al. 
2004, Shirasu et al. 2003). In this model, RAR1-independent NB-LRR protein levels 
remain above a threshold that is high enough to activate defense responses, even in 
rar1 mutants. In contrast, RAR1-dependent NB-LRR protein levels drop below a 
functional signaling threshold in a rar1 background. The genetic requirement for 
RAR1 is quantitatively determined by steady state NB-LRR protein levels (Holt et al. 
2005). Except for causing defects in NB-LRR levels and functions, rar1 mutants do 
not have any additional observable phenotype. This suggests that RAR1, a single-
copy gene in plants, functions exclusively in the plant immune system.  
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RAR1 encodes a protein with two highly similar but distinct cysteine- and histidine-
rich (CHORD) domains, each binding two zinc ions individually. A plant-specific 
cysteine- and histidine-containing (CCCH) domain is located between these two 
CHORD domains binds a fifth zinc ion (Heise et al. 2007). The structure of tandem 
CHORD domains is highly conserved in many eukaryotes, and CHORD containing 
proteins (CHPs) have been identified in all tested eukaryotes except for yeast and 
Chlamydomonas (Shirasu 2009). Interestingly, the CHP-encoding genes in animals 
and humans have been connected to development, but not to any immunity 
response, indicating that RAR1 and its homologs may play diverse roles in various 
cellular activities (Brancaccio et al. 2003, Shirasu et al. 1999).  
In Arabidopsis, the sgt1b mutant has been reported as a rar1 suppressor that 
suppressed rar1 for reduced NB-LRR RPS5 protein accumulation and loss of RPS5-
mediated resistance responses (Holt et al. 2005). As a regulator of NB-LRR function, 
SGT1, was identified in plants by two different approaches: a yeast two-hybrid 
screen for RAR1 interactors (Azevedo et al. 2002) and a forward genetic screen 
looking for mutations affecting the resistance function of RPP5, a TIR-NB-LRR 
(Austin et al. 2002, Tör et al. 2002). In barley and Nicotiana benthamiana, silencing 
of SGT1 attenuates the resistance responses mediated by some NB-LRR proteins 
encoding genes, indicating that SGT1 plays an important role in regulating R 
proteins function (Austin et al. 2002, Peart et al. 2002). Arabidopsis has two SGT1 
genes, SGT1a and SGT1b, and only SGT1b is shown to have a role in immune 
function. Loss of SGT1b function suppresses resistance functions of NB-LRR RPP2, 
RPP4, RPP5, and RPP7 proteins that recognize the oomycete pathogen 
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Hyaloperonospora arabidopsis (Hpa) isolates Cala2, Emwa1, Noco2, and Hiks1 
respectively (Holt et al. 2005).  
Unlike RAR1, which only functions in plant immunity, SGT1 acts in multiple plant 
cellular processes. For example, the Arabidopsis sgt1a sgt1b double mutant is 
embryo lethal, suggesting that SGT1 plays an essential role in plant growth and 
development (Azevedo et al. 2006). In addition, SGT1 is also involved in auxin and 
JA responses (Gray et al. 2003). This involvement indicates that SGT1 may be a 
crosstalk factor connecting phytohormone signaling pathways and NB-LRR 
mediated resistance responses. This concept will become important in Chapter 3. 
SGT1 is highly conserved in eukaryotes including yeast and Chlamydomonas. In 
yeast, SGT1 is required for cell cycle regulation and other important biological 
processes (Kitagawa et al. 1999). The plant and human SGT1 genes can rescue the 
cell cycle defects in yeast sgt1 mutants, demonstrating that the biochemical activity 
of SGT1 protein is also highly conserved (Azevedo et al. 2002). In human cells, 
SGT1 is required for NLR protein MLRP3-mediated inflammatory responses and 
NLR protein NOD1 activity (da Silva Correia et al. 2007, Mayor et al. 2007). Hence, 
SGT1 homologs function in regulating both plant NB-LRR proteins and human NLR 
proteins. 
SGT1 was originally identified in yeast as a suppressor of the skp1 mutant 
(Kitagawa et al. 1999). The same study also found that SGT1 physically interacts 
with SKP1 in yeast and SGT1 is required by the yeast SCFcdc4 (SKP1-cdc53p-cdc4) 
ubiquitin ligase complex to mediate Sci1p protein degradation. These results 
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demonstrated that SGT1 associates and functions with an SCF complex via the SCF 
component SKP1 in yeast. Since SGT1 is highly conserved in eukaryotes, the 
finding in yeast indicates that SGT1 also functions with various SCF complexes in 
other species. In plants, this hypothesis is supported by multiple observations: 1) 
SGT1b associates with two SCF components, SKP1 and Cullin1, in plants (Azevedo 
et al. 2002, Liu et al. 2002); 2) In Arabidopsis, SGT1b is required for at least two 
SCF-mediated hormone responses: JA and auxin responses (Gray et al. 2003); 3) 
SGT1b also interacts with the COP9 signalosome (CSN) which inactivates the SCF 
complex by removing NEDD8 from Cullin1 (Azevedo et al. 2002, Liu et al. 2002, 
Lyapina et al. 2001); 4) Both SGT1 and SKP1 silencing in N. benthamiana plants 
resulted in elevated susceptibility to tobacco mosaic virus (TMV), suggesting that 
both of these genes are required for NB-LRR N protein-mediated disease resistance 
responses (Liu et al. 2002).  
In addition to working with SGT1, SCF complex also affects plant disease resistance 
by directly regulating the accumulation levels of NB-LRR proteins. Recently, the 
SCFCPR1 complex was reported to negatively regulate the stabilities of two NB-LRR 
proteins, SNC1 and RPS2, via the F-box protein CPR1 which is a component of the 
SCFCPR1 (Cheng et al. 2011). CPR1 bound to SNC1 and RPS2 in Arabidopsis and 
initiated the ubiquitin-mediated degradation of these two NB-LRR proteins. The 
degradation consequently weakened the disease resistance responses mediated by 
SNC1 and RPS2. This finding demonstrated again that SCF-mediated protein 
degradation plays a role in plant defence.  
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From my own rar1 suppressor screen, two specific alleles of hsp90.2 mutants were 
identified that suppress all known rar1 phenotypes including reduced NB-LRR 
protein accumulation and loss of NB-LRR-mediated resistance to pathogens (Hubert 
et al. 2009). Like the SGT1b case, a third regulator of NB-LRRs, cytosolic HSP90, 
was also identified by both a yeast two-hybrid screen and a forward genetic screen 
(Hubert et al. 2003, Takahashi et al. 2003). From the forward genetic screen, four 
mutant alleles of the Arabidopsis HSP90.2 gene were isolated for loss of RPM1-
mediated resistance responses to P. syringae expressing AvrRpm1. All the 
mutations are in the ATPase domain of HSP90.2. However, an HSP90.2 knockout 
line (null mutation) does not impair the function of RPM1 (Hubert et al. 2003). 
Therefore, the hsp90.2ATPase mutants are recessive gain-of-function alleles. 
Arabidopsis has four cytosolic HSP90 isoforms. HSP90.1 is reported to be required 
for full function of RPS2 (Takahashi et al. 2003), though this result cannot be 
reproduced in our hands. In addition, silencing of HSP90 genes impairs N-mediated 
resistance to tobacco mosaic virus (TMV), Rx-mediated resistance to Potato virus X 
(PVX) and Pto-mediated resistance to P. syringae expressing AvrPto (Liu et al. 2004, 
Lu et al. 2003). These findings demonstrate that HSP90 also plays an important role 
in regulating functions of NB-LRRs.  
In addition to disease resistance, HSP90 is also essential for plant growth and 
development. Loss of HSP90 function can be a severe threat to plant survival. The 
Arabidopsis hsp90.2-5KO hsp90.1KO double mutant is lethal, and plants homozygous 
for hsp90.1KO and heterozygous for hsp90.2-5KO display dwarf phenotype and very 
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low fecundity (Hubert et al. 2009). In N. benthamiana, silencing of NbHSP90.1 
results in stunted plant development and plant death (Liu et al. 2004). 
HSP90 is a highly conserved and abundant housekeeping protein in all eukaryotes. 
As a cytosolic molecular chaperone, HSP90 functions in folding, stabilizing, 
activating, and assembling target proteins, termed client proteins, to regulate various 
cell processes (Picard 2002). RPM1, a CC-NB-LRR protein, was the first identified 
client protein for plant HSP90 based on three lines of evidence: 1) RPM1 directly 
interacts with HSP90 in vivo; 2) RPM1 function is impaired by the hsp90.2ATPase 
mutations; 3) The accumulation levels of steady state RPM1 are greatly reduced in 
the hsp90.2ATPase mutant plants(Hubert et al. 2003). Furthermore, the rar1 
suppressor (rsp) alleles of hsp90.2, hsp90.2-7rsp and hsp90.2-8rsp, restored RPM1 
accumulation and RPM1-mediated resistance responses in rar1. These are the first 
example of mutations in HSP90 proteins that result in a recovery of client protein 
accumulation and function (Hubert et al. 2009). Interestingly, a mammalian NLR 
protein, NOD1, was also demonstrated to be a client protein of HSP90 (Hahn 2005). 
These data suggest that regulating immunity sensor protein activity, and 
consequently immunity responses, is a common function of HSP90 chaperones in 
both plants and animals.  
RAR1, SGT1 and HSP90 cooperate as a molecular chaperone complex to regulate 
the stabilities and functions of NB-LRRs (Kadota et al. 2010, Shirasu 2009). All three 
of these proteins can interact with one another: the CS domain of SGT1, or the 
CHORD I domain of RAR1, can interact with the N-terminal ATPase domain of 
HSP90; the CHORD II domain of RAR1 also interacts with the CS domain of SGT1 
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(Azevedo et al. 2006, Hubert et al. 2003, Takahashi et al. 2003) (Fig. 1.2a). The 
SGT1-HSP90 interaction has been demonstrated to be required for SGT1 function 
(Botër et al. 2007). Mutation of SGT1b can genetically suppress rar1 for some NB-
LRR functions, but not all (Holt et al. 2005). Also, two specific hsp90.2 alleles were 
identified to suppress all known rar1 phenotypes (Hubert et al. 2009).  
Although the functional mechanism of the RAR1-SGT1-HSP90 complex still remains 
poorly understood, the chaperone HSP90 is usually thought to be the central subunit 
of the complex. Client NB-LRR proteins rely on HSP90 for stability and/or function. 
In its N-terminal ATPase domain, HSP90 contains a lid segment that swings through 
nearly 180° from its open position in the ADP-bound form to a closed ATP-bound 
conformation (Fig. 1.2b). This movement locks in the ATP molecule, and positions 
the catalytic arginine (371 in Arabidopsis; 380 in yeast) to interact with the 
phosphate of ATP (Fig. 1.2b). This movement also facilitates formation of the HSP90 
N-terminal dimerization clasp (Ali et al. 2006). Based on analyses of mutations and 
crystal structure, RAR1 is expected to destabilize the lid-closed conformation of the 
HSP90, and induce the lid-open conformation that is important for loading NB-LRR 
clients (Fig. 1.2c) (Hubert et al. 2009, Zhang et al. 2010).  
COI1 regulates accumulation and disease resistance functions of NB-LRR 
proteins  
I also identified two missense alleles of COI1 in my rar1 suppressor (rsp) screen. 
These coi1rsp alleles recover RPM1 protein accumulation and some NB-LRR-




Fig 1.2. Working Model of RAR1-SGT1-HSP90 chaperone complex.  
(this figure repeatedly appears in the background and significance sections in the 
chapter 4).  
a. RAR1, SGT1 and HSP90 proteins interact with one another. This figure was 
drawn by David Hubert.  
b. The HSP90 cycle. The HSP90 cycle includes several transitions of HSP90 
conformation. Binding of ATP promotes a closed conformation. The lid structure 
swings to lock in the ATP molecule. After ATP hydrolysis, HSP90 adopts an open 
conformation. This figure is drawn, with some changes, after the figures in reference 
(Hartl et al. 2011). 
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c. RAR1 and SGT1 bind to the HSP90 ATPase domain and consequently compete 
for regulating HSP90 conformation. RAR1 is expected to destabilize the lid-closed 
conformation of the HSP90, and induce the lid-open conformation that is important 
for loading NB-LRR clients. This figure is drawn, with some changes, after the 
















mutant background. The COI1 gene encodes a well-characterized receptor of 
phytohormone Jasmonic Acid (JA). COI1-mediated JA signaling is one of the 
phytohormone pathways involved in regulating disease resistance. COI1 was 
originally isolated based on the insensitivity of its mutant alleles to a JA mimic, 
coronatine (COR) (Feys et al. 1994).  
COR is a phytotoxin produced by some plant pathogenic bacteria, including the 
commonly used model strain, Pto DC3000 (Benedetti et al. 1995, Boland et al. 1995). 
As a virulence factor, COR acts to promote pathogen growth, producing chlorosis 
symptoms, and spreading necrotic lesions. In tomato leaves, the COR production-
incompetent (COR-) mutant bacteria Pto DC3682 grows to 1000-fold lower levels 
than wild-type Pto DC3000 at 7 days post-inoculation. Furthermore, no symptoms 
were observed on the leaves inoculated with Pto DC3682. These findings indicate 
that COR plays an essential role in virulence of pathogenic bacteria that can 
produce it (Bender et al. 1987, Penaloza-Vazquez et al. 2000).  
As mentioned above, COR contributes to bacterial virulence by activating JA 
signaling in host plants. This conclusion is supported by several kinds of evidence: 1) 
COR is a molecular mimic of JA-isoleucine (JA-Ile), a JA-amino acid conjugate. Both 
COR and JA-Ile are highly active in promoting the interaction between COI1 protein 
and JASMONATE ZIM domain (JAZ) proteins, negative regulators of JA dependent 
transcription of defense genes (Chini et al. 2007, Sheard et al. 2010, Thines et al. 
2007, Yan et al. 2009). This is a critical step of JA signaling. Surprisingly, COR is 
around 1000-fold more effective than JA-Ile in stimulating JAZ1-COI1 and JAZ3-
COI1 interactions (Katsir et al. 2008); 2) In plants, COR and JA induce the same set 
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of physiological processes including inhibition of root elongation, anthocyanin 
accumulation, expression of vegetative storage proteins, odor emission, ethylene 
production, biosynthesis of proteinase inhibitors and tendril coiling (Benedetti et al. 
1995, Boland et al. 1995, Feys et al. 1994, Greulich et al. 1995, Palmer et al. 1995, 
Weiler et al. 1994); 3) A comparison of the transcriptional profiles of COR- and 
Methyl Jasmonate (MeJA)-treated tomato leaf tissues demonstrates that COR 
regulates 35% of the MeJA-induced genes (Uppalapati et al. 2005); 4) The COR-
insensitive mutant, coi1, also shows insensitivity to JA. All tested JA-dependent 
phenotypic responses are suppressed in coi1 mutants, suggesting that COR and JA 
share a common signaling pathway (Li et al. 2004, Paschold et al. 2007, Wang et al. 
2005, Xie et al. 1998); 5) Treatment with exogenous MeJA can complement the 
virulence defect of the COR- mutant Pto DC3118, indicating that COR and JA are 
functionally similar to each other(Zhao et al. 2003). 
In addition to the coi1rsp alleles described in this study, more than 20 alleles of 
Arabidopsis coi1 have been isolated from different genetic screens (Ellis et al. 2002, 
Feys et al. 1994, Kloek et al. 2001, Xie et al. 1998, Yan et al. 2009). Unlike the 
coi1rsp alleles, all other coi1 mutants are male sterile. The flowers of these coi1 
mutant plants can only develop extremely short siliques, and fail to produce any 
seeds. The sterile flowers can be successfully fertilized with wild-type pollen. 
However, pollen from the mutant plants cannot fertilize wild-type flowers. Hence, 
those coi1 alleles are male sterile and female fertile (Feys et al. 1994).  
The male sterility phenotype includes three developmental defects (Feys et al. 1994, 
Thines et al. 2007): 1) The coi1 anther filaments are too short for stamens to finish 
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pollination at the time of flower opening; 2) The coi1 anthers do not dehisce at the 
time of fellow opening; 3) The coi1 pollen grains are obviously smaller than wild-type 
pollen grains, and contain vacuoles. In addition, the coi1 pollens fail to germinate on 
specific media.  
It has been reported that coi1-16, a missense allele (L245F) of COI1, displays a 
conditional male sterility phenotype. The coi1-16 plants are fertile at 16 degree C, 
but sterile at 22 degree C (Ellis et al. 2002). Although it might be due to an 
unexpected second mutation in the coi1-16 genome (Westphal et al. 2008), this 
interesting phenotype still implies that COI1 possibly functions in the crosstalk 
between JA signaling and temperature condition. 
As well as coi1, Arabidopsis mutants with defects in JA biosynthesis, such as fad3 
fad7 fad8 triple mutant, dad1, aos, and opr3, are also male sterile (Browse 2009). 
The sterility of these mutants can be complemented by the treatment of exogenous 
JA (Ishiguro et al. 2001, McConn et al. 1996, Stintzi et al. 2000). These results 
demonstrate that JA signaling plays a necessary role in reproductive development.  
In addition to JA responses and reproductive development, mutations in COI1 also 
affect, negatively or positively, disease resistance against various plant pathogens 
(Table 1.1). It is widely accepted that the defense phenotypes of coi1 depend on the 
antagonism between SA and JA signaling pathways (Kunkel et al. 2002). As 
discussed earlier, the virulence function of COR also relies on SA-JA crosstalk. COR 
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In contrast, mutations in COI1 block JA-signaling, and consequently enhance SA 
signaling and SA-induced defense responses. The defense-related phenotypes of 
Arabidopsis coi1 mutants are listed in table 1.1, together with the relevant references. 
These phenotypes suggest that COI1 is a key point of crosstalk between JA 
signaling and disease resistance. 
COI1 encodes an F-box protein with 18 tandem leucine-rich repeats (Sheard et al. 
2010). It is a component of the SCFCOI1
 
(Skip/Cullin/F-boxCOI1) E3 ubiquitin ligase 
complex (Xie et al. 1998, Xu et al. 2002) (Fig. 1.3). The SCF E3 complex is required 
for ubiquitin-mediated protein degradation. The function of the F-box is to specifically 
bind to target proteins so that they can be ubiquitinated by the SCF complex and 
then degraded by the 26S proteasome. COI1 binds to target proteins via its LRR 
domain (Sheard et al. 2010, Yan et al. 2009). As COI1 is identified as an F-box 
protein, it is therefore assumed that COI1 regulates JA signaling and disease 
resistance via degradation of specific proteins. This hypothesis is partially supported 
by the JA phenotypes observed in the Arabidopsis mutants of the genes encoding 
other SCF components including SKP1, Cullin1 and RBX1 (Browse 2009, Moon et al. 
2004). The connection between JA signaling and SCFCOI1-mediated protein 
degradation has been confirmed. JAZ family proteins act as repressors of MYC2, a 
key transcriptional activator of JA responses, by directly interacting with MYC2. JA-
Ile, a bioactive JA conjugate, induces the degradation of JAZ proteins by enhancing 
the protein interaction between JAZs and COI1, and thus de-represses JA-related 
transcription activation (Fig. 1.3) (Chini et al. 2007, Sheard et al. 2010, Thines et al. 
2007, Yan et al. 2009).  
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However, the target of SCFCOI1
 
in disease resistance is still unclear. Although it has 
been reported that a JAZ family protein, JAZ1, affects the disease resistance 
response against Pto DC3000 (Thines et al. 2007), SCFCOI1 likely has other target(s) 
to regulate NB-LRR-mediated disease resistance responses. As mentioned above, 
some literature suggests that the NB-LRR regulator SGT1b associates and functions 
with SCF complex in plants. Hence, SGT1b might be a target of a COI1-containing 
SCF. Moreover, I also observed that the coi1rsp alleles genetically interact with rar1, 
sgt1b and hsp90.2 to regulate disease resistance responses mediated by some NB-
LRRs and the accumulation of at least RPM1. These results, detailed in Chapter 3, 
support the hypothesis that COI1 functions in mediating the degradation of NB-LRR 
proteins via the RAR1-SGT1-HSP90 chaperone complex.  
 
Figure 1.3.  Model for the SCFCOI1-mediated JA responses.  
In a non-stimulated situation, the transcriptional activator MYC2 is bound and repressed by 
JAZ proteins. The repression requires two co-repressor proteins, NOVEL INTERACTOR of 
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JAZ (NINJA) and TOPLESS (TPL). Upon environmental stimulations, JA-Ile is synthesized 
by JAR1, and consequently promotes the interaction between JAZ proteins and F-box 
protein COI1. Then JAZ proteins ubiquitinated by SCFCOI1 are degraded by the 26S 
proteasome. The degradation of JAZ proteins releases MYC2, and turns the JA signaling 
pathway on (Chini et al. 2007, Pauwels et al. 2010, Sheard et al. 2010, Thines et al. 2007). 
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Specific Arabidopsis HSP90.2 alleles recapitulate the function of RAR1 in plant 
NB-LRR disease resistance protein co-chaperones  
 
PREFACE 
The following chapter was published in Proceedings of the National Academy of 
Sciences (2009, 106, 9556-9563). I share co-first authorship with David Hubert. For 
this paper, I made intellectual contributions to designing the experiments for the 
whole paper and generated the data presented in figure 2.1B, 2.2B and 2.3-2.6. 
Additionally, I created these figures and table 2.1, and wrote the corresponding part 
of the manuscript. Figures and table were re-numbered for this chapter. 
 
ABSTRACT 
Both plants and animals require the activity of proteins containing nucleotide binding 
domain and leucine-rich repeat domains for proper immune system function. NB-
LRR proteins in plants (NLR proteins in animals) also require conserved regulation 
via the proteins SGT1 and cytosolic HSP90. RAR1, a protein specifically required for 
plant innate immunity, interacts with SGT1 and HSP90 to maintain proper NB-LRR 
protein steady state levels. Here, we present the identification and characterization 
of specific mutations in Arabidopsis HSP90.2 that suppress all known phenotypes of 
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rar1. These mutations are unique from alleles of HSP90 identified in any system in 
that they can bypass the requirement for a co-chaperone, and result in the recovery 
of client protein accumulation and function. Additionally, these mutations separate 
HSP90 ATP hydrolysis from HSP90 function in client protein folding and / or 
accumulation. By recapitulating the activity of RAR1, these novel hsp90 alleles allow 
us to propose that RAR1 regulates the physical open-close cycling of a known ‘lid 
structure’ that is used as a dynamic regulatory HSP90 mechanism. Thus, in rar1, lid 
cycling is locked into a conformation favoring NB-LRR client degradation, likely via 
SGT1 and the proteasome. 
 
INTRODUCTION 
Plants have evolved a highly complex immune system centered on pathogen 
recognition via the evolutionarily conserved NB-LRR proteins. Pathogen triggered 
activation of NB-LRR proteins leads to several responses including cell wall 
strengthening, transcriptional reprogramming, and a form of programmed cell death 
termed the hypersensitive response (HR). Because their function often results in cell 
death, proper maintenance of NB-LRR protein levels and activation state are vital to 
the health of the plant (Jones et al. 2006). 
NB-LRR proteins can be divided into two structural sub-groups based on the 
presence of either a likely coiled-coil (CC) or Toll-Interleukin 1 Receptor (TIR) 
domain at their N-termini. This is followed in both sub-groups by a middle nucleotide 
binding site (NB) and a C-terminal leucine-rich repeat (LRR). This general structure 
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is not only conserved across all plants but extends to NOD/Caterpiller/NLR proteins 
that mediate various processes in mammalian innate immunity (Ting et al. 2008).  
Just as the domain composition of these intracellular receptors is conserved from 
plants to animals, so is the regulation of their steady state accumulation. Cytosolic 
HSP90 and the co-chaperone SGT1 have been previously demonstrated to not only 
be important for regulation of NB-LRR proteins in plants, but also in regulation of 
NLR function in animals (Ye et al. 2008). A third protein called RAR1 appears to play 
a role in innate immunity specifically in plants (da Silva Correia et al. 2007). 
All three of these proteins can independently interact with one another; the CS 
domain of SGT1b, or the CHORDI domain of RAR1, can interact with the N-terminal 
ATPase domain of HSP90; the CHORDII domain of RAR1 also interacts with the CS 
domain of SGT1 (Takahashi et al. 2003). The interaction of SGT1 with HSP90 has 
been shown to be required for SGT1 function (Boter et al. 2007). Mutation of SGT1 
can suppress rar1 for some NB-LRR functions, but not all (Holt III et al. 2005). 
However, the relationship between RAR1 and HSP90 is less understood. 
We present and characterize specific missense alleles of HSP90.2 in the reference 
plant, Arabidopsis, that suppress rar1. These hsp90.2 alleles are uniquely interesting 
in that they can bypass the requirement for a co-chaperone, and result in recovery of 
client protein accumulation and function. 
We used genetic and biochemical analyses to demonstrate that these hsp90.2 
mutant proteins act on NB-LRR proteins affected by rar1, suppressing all identified 
rar1 phenotypes. We further show that these mutations are functionally distinct from 
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previously identified hsp90.2 mutations (Hubert et al. 2003), including a null allele. 
These specific missense changes in hsp90.2 enable a separation of HSP90 ATP 
hydrolysis activity and HSP90 function in client protein accumulation. By 
recapitulating the activity of RAR1 in its absence, these phenotypes of these 
hsp90.2 mutants strongly suggest that RAR1 physically enhances the transition 
state of HSP90 as it moves from a ‘lid open’ ADP bound conformation to a ‘lid closed’ 
ATP bound conformation.  
 
RESULTS 
Identification of new alleles of RAR1 and HSP90 
In order to identify new genes required for RPM1 function in Arabidopsis, we 
performed two genetic screens. Both took advantage of sensitized genetic 
backgrounds. The first was a modification of a previous screen (Tornero et al. 
2002a), using a β-estradiol-inducible copy of the avrRpm1 bacterial type III effector 
gene whose product is recognized in Arabidopsis by the RPM1 NB-LRR protein (Fig. 
2.1). Given the very high recovery ratio of rpm1 alleles compared to second site loci 
isolated previously (Tornero et al. 2002a), we modified the screen by crossing into 
this background a well characterized transgenic, myc-epitope tagged copy of RPM1 
expressed from the native promoter (Fig. 2.1A); (Boyes et al. 1998). Approximately 
one million M2 plants were screened from 200 EMS-mutagenized seed lots. Putative 
surviving mutants were then assayed for loss of disease resistance in response to 
pathogen delivered AvrRpm1 to eliminate mutations in the estradiol-inducible system 
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(Materials and Methods). 
Various candidate genes previously implicated in RPM1 function were then 
sequenced in the remaining putative mutants. These included: the endogenous copy 
of RPM1, the transgenic copy of RPM1-myc, RAR1, and all four genes encoding 
Arabidopsis cytosolic HSP90 (Boyes et al. 1998, Hubert et al. 2003, Tornero et al. 
2002a, Tornero et al. 2001). Four new mutations in RAR1, and one new allele of 
HSP90.2 were found, hsp90.2-6 (Fig. 2.2). The rar1 alleles are consistent with 
previous mutations: premature stops, splicing defects, and disruption of zinc-
coordinating residues (Muskett et al. 2002, Tornero et al. 2002b). The newly-
identified allele of hsp90.2 displayed intermediate susceptibility and full penetrance, 
as previously found for hsp90.2-1 and -3 (Hubert et al. 2003). Additional mutants are 
currently being characterized and will be discussed elsewhere. 
The second screen was a rar1 suppressor screen (Fig. 2.1B), aimed at  identifying 
loci that would restore the loss of NB-LRR protein accumulation, and consequent 
loss of function, that are the principal rar1 phenotypes (Tornero et al. 2002b). 
Roughly 200,000 EMS mutagenized M2 individuals from 50 M1 seed lots of rar1-21 
were spray-inoculated with Pto DC3000(avrPphB) (Materials and Methods). This 
strain is recognized in Arabidopsis by the RPS5 NB-LRR protein  (Warren et al. 
1998). We used RPS5 as the read-out in this screen because rar1 exhibits a strong 
identifying loci that would restore the loss of NB-LRR protein accumulation, and 
consequent loss of function, that are the principal rar1 phenotypes (Tornero et al. 
2002b). Roughly 200,000 EMS mutagenized M2 individuals from 50 M1 seed lots of 









These flow charts depict the process conducted in both genetic screens.  
(A) The ‘Double RPM1 Screen’ began with wild-type Columbia-0 plants expressing RPM1. 
An estradiol-inducible version of the bacterial gene AvrRpm1 was introduced along with an 
RPM1 transgene carrying a myc-epitope tagged version of RPM1 under the control of its 
native promoter (Boyes et al. 1998, Tornero et al. 2002b). This line was mutagenized, and 
~100 M1 plants were allowed to self in each of 200 separate pools or lots. AvrRpm1 
expression in the resulting M2 plants was induced with estradiol. Seed was collected from 
non-responsive plants. These M3 plants were then tested for resistance to Pto 
DC3000(avrRpm1). This step allowed the identification and removal of plants with mutations 
in the estradiol-inducible expression system.  
(B) The rar1 suppressor screen was begun by mutagenizing rar1-21 mutant seed (Tornero 
et al. 2002b) carrying the same estradiol-inducible version of AvrRpm1 as in A. The resulting 
M1 plants were allowed to self in 50 separate lots. M2 plants were sprayed Pto 
DC3000(avrPphB). Disease resistant plants were allowed to self, and resulting M3 plants 
were retested by dip inoculation in separately in both Pto DC3000(avrPphB) and (avrRpm1) 










Figure 2.2. Schematic representations of Arabidopsis RAR1 and HSP90.2 
showing the location of all known mutant alleles.  
New alleles introduced in this paper are underlined and in red.  
(A) Identified mutations in RAR1. The CHORD-I domain is shown in red, the CCCH region is 
shown in blue, and the CHORD-II domain is shown in green. The allele designation and 
associated amino acid change is shown in relation to its linear position. The ecotypes in 
which the mutants were identified are shown below. Non-coding mutations are described 
below the linear molecule.  
(B) Identified mutations in HSP90.2. The ATPase domain is shown in red, the middle 
domain is shown in blue, and the C-terminal dimerization domain is shown in green. The 
phenotype of the respective mutation is indicated after the allele designation and associated 






This strain is recognized in Arabidopsis by the RPS5 NB-LRR protein  (Warren et al. 
1998). We used RPS5 as the read-out in this screen because rar1 exhibits a strong 
and uniform disease susceptibility phenotype to Pto DC3000(avrPphB). We 
reasoned that a suppressor would be obviously disease resistant against this 
susceptible background. 
We identified five independent second site mutants defining three loci in this screen. 
While hsp90.2 has previously been shown to have no effect on RPS5 (Hubert et al. 
2003), two of the mutants are missense mutations in the hsp90.2 gene based on 
map-based cloning and subsequent sequencing of both mutant alleles (Fig. 2.2B). 
The other two loci will be discussed elsewhere. To avoid confusion, we will 
henceforth refer to hsp90.2 alleles which lose RPM1 function by the original notation, 
lra (loss of recognition of avrRpm1; (Tornero et al. 2002b), and alleles which 
suppress rar1 as rsp (rar1 suppressor). Like all the lra alleles, hsp90.2-7
rsp
 is 
completely recessive. On the other hand, based on disease symptoms after bacterial 
inoculation, hsp90.2-8rsp behaves as a weak semi-dominant allele (Materials and 
Methods). 
The hsp90.2rsp alleles suppress all known rar1 phenotypes 
Inexplicably, hsp90.2lra alleles were previously shown to specifically impact RPM1 
function, and not the function of other tested NB-LRR proteins (Hubert et al. 2003). 
Conversely, rar1 affects the steady state accumulation of all tested NB-LRR proteins, 
and the function of many, by lowering their accumulation below a functional 
threshold (Bieri et al. 2004, Holt III et al. 2005). Hence, we did not expect to identify 
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hsp90.2 alleles in our RPS5-based rar1 suppressor screen. We determined whether 
the rsp alleles suppressed rar1 phenotypes of other NB-LRR-dependent disease 
resistance specificities. The hsp90.2rsp alleles variably suppressed rar1 with respect 
to RPS5 (Fig. 2.3A), RPM1 (Fig. 2.3B) and RPS2 (Fig. 2.3C) function.  
rar1 mutants express decreased basal disease resistance to the virulent pathogen 
Pto DC3000 (Holt III et al. 2005). The only molecular phenotype ever ascribed to 
rar1 is diminution of steady state NB-LRR protein accumulation noted above. Thus, 
this phenotype suggests an as yet undocumented role for RAR1 on NB-LRR 
proteins that might either function in basal defense and / or weak recognition of the 
type III effectors delivered by Pto DC3000 (Chang et al. 2005). Notably, both 
hsp90.2rsp alleles also suppress this phenotype (Fig. 2.3D).  
We used the release of ions into solution by inoculated plant leaf discs to measure 
the ability of hsp90.2rsp to suppress the loss of HR associated with rar1 (Torres et al. 
2002). While neither rpm1 nor rar1 are able to generate an HR upon delivery of 
AvrRpm1, rar1 hsp90.2rsp double mutants display the same level of HR as wild-type 
Col-0 plants (Fig. 2.3E). The suppression of this particular rar1 phenotype is in 
marked contrast to results obtained with sgt1b as a rar1 suppressor (Holt III et al. 
2005). 
We next assayed whether the hsp90.2rsp alleles were able to suppress the most 
direct rar1 mutant phenotype, a decrease in NB-LRR protein accumulation (Tornero 
et al. 2002b). We introgressed a transgenic RPM1-myc-epitope tagged derivative 




Figure 2.3. rsp alleles suppress all known rar1 phenotypes.  
(A-D) Bacterial growth assays comparing rar1 mutants to hsp90.2rsp rar1 double mutants. 
Note the logarithmic scale. hsp90.2rsp mutants suppress rar1 phenotypes for disease 
resistance mediated by (A) RPS5, (B) RPM1, and (C) RPS2. (D) hsp90.2rsp mutants 
suppress the rar1 phenotype of decreased basal resistance to Pto DC3000 (Holt III et al. 
2005). (E) hsp90.2rsp alleles suppress the rar1 phenotype conductivity is indicative of the 
release of ions from cells undergoing HR. (F) hsp90.2rsp alleles suppress the rar1 phenotype 




In these double mutants, the hsp90.2rsp alleles suppressed the very low RPM1 
accumulation observed in rar1 (Fig. 2.3F). Hence, the hsp90.2rsp alleles suppress 
the key biochemical phenotype of rar1, at least with respect to RPM1 and probably 
more generally, given the pathology data presented in figure 2.3. 
Because RPM1, RPS2 and RPS5 are CC-NB-LRR proteins, we addressed whether 
a RAR1-dependent, TIR-NB-LRR protein is also suppressed by the hsp90.2rsp 
alleles. RPP4 conditions disease resistance to the oomycete pathogen, 
Hyaloperonospora parasitica (Hpa) (van der Biezen et al. 2002). In this case, the 
hypersensitive response (HR) is likely to be required for disease resistance, while it 
is likely to be dispensable for resistance to bacterial pathogens. We noted that both 
hsp90.2rsp rar1 lines expressed higher RPP4 function than rar1 (Fig. 2.4A) and 
exhibited higher levels of HR (Fig. 2.4B). Hence, the hsp90.2rsp alleles also suppress 
rar1 for a TIR-NB-LRR, and in a context where HR is likely to be the key mechanism 
of disease resistance. 
The possibility existed that the recovery of disease resistance observed in hsp90.2rsp 
rar1 double mutants is not specific, but rather a result of general metabolic 
perturbation resulting in disease resistance. Such perturbations are typically 
accompanied by an increase in the levels of defense marker proteins  such as PR-1 
(Belkhadir et al. 2004). However, we did not observe an obvious increase in PR-1 
levels in hsp90.2rsp lines. 
We previously demonstrated that a presumed truncated protein product made by the 




Figure 2.4. hsp90.2rsp alleles suppress the rar1 effect on RPP4, a TIR-NB-LRR, in 
response to an oomycete pathogen, Hyaloperonospora arabidopsidis isolate Emwa1.  
(A) The RAR1-dependent TIR-NB-LRR protein RPP4 conditions recognition of the Hpa 
isolate Emwa-1 in wild-type Col-0 plants. Consequently there is no oomycete sporulation in 
these plants. RAR1 is required for RPP4-mediated recognition. Consequently, rar1 mutants 
display a high level of Hpa reproduction. hsp90.2rsp rar1 double mutants both display more 
sporangiophores than wild-type plants but less than a rar1 single mutant, suggesting partial 
suppression of rar1 for RPP4 function. Colored bars refer to number of sporangiophores 
counted per cotyledon. Minimum of 20 cotyledons per genotype.  
(B) Trypan blue staining of dead plant cells and oomycete hyphal structures is shown. Dead 
xylem cells in the vascular bundle can be seen in all genotypes. While areas of death 
representing a hypersensitive response can be seen in Col-0, fine hair-like hyphae can be 
seen in, and reproductive sporangiophores are shown radiating from, the rar1 cotyledon. 
The hsp90.2rsp rar1 double mutants support intermediate levels of Hpa growth and the 





is, surprisingly, able to co-immunoprecipitate HSP90. This co-immunoprecipitation 
was not observed with the rar1-20 null allele, or the W47stop allele, rar1-28 (Hubert 
et al. 2003); Y. Belkhadir and J. Dangl, unpublished data). We constructed rar1-28 
hsp90.2rsp combinations for both rsp alleles. We assayed for RPM1 function in order 
to rule out the possibility of a rar1 allele-specific effect. We clearly observed 
suppression of the rar1 phenotype in rar1-28 hsp90.2rsp double mutants; hence the 
effect of the rsp alleles on RPM1 function is not rar1-21 allele specific.  
 
The hsp90.2rsp alleles have no phenotype in RAR1 
We isolated the hsp90.2rsp single mutants by backcrossing, and assayed them for 
RPM1 function. As seen in figure 2.5A, the hsp90.2rsp single mutants express wild-
type RPM1 function. Hence, the hsp90.2rsp single mutants are phenotypically distinct 
from the hsp90.2lra alleles (Hubert et al. 2003), which all express partial loss of 
RPM1-mediated disease resistance. We also monitored HR in the hsp90.2rsp single 
mutants. hsp90.2rsp alleles again expressed wild-type phenotypes (Fig. 2.5B).  
The HSP90.2rsp proteins might counterbalance the decrease in NB-LRR protein 
accumulation observed in rar1 by conditioning ‘hyper-accumulation’ above wild-type 
levels. We thus introgressed RPM1-myc into each hsp90.2rsp mutant and assayed 
for RPM1-myc protein accumulation. We detected wild-type RPM1-myc protein 
levels in the single mutant lines. We conclude that there is no increased NB-LRR 
protein activity indicative of ‘hyper-chaperoning’ by the hsp90.2rsp alleles. Thus, 




Figure 2.5. hsp90.2rsp mutants are phenotypically distinct from an hsp90.2lra 
single mutant and an hsp90.2 T-DNA insertion null mutant.  
hsp90.2rsp, hsp90.2lra, and hsp90.2KO single mutant plants are compared to each other and 
to Col-0 and rpm1 plants.  
(A) Bacterial growth assay for recognition of Pto DC3000(avrRpm1) by RPM1.  
(B) Conductivity assay measuring the HR triggered by RPM1 activation following recognition 





merely overcoming the rar1 phenotype by increased overall expression of client 
protein. 
 
The hsp90.2lra and hsp90.2KO alleles do not suppress rar1 
We next tested if either hsp90.2KO or a reference hsp90.2-3lra allele (encoding D80N, 
a mutation analogous to the well-studied yeast D79N; (Prodromou et al. 1997) could 
suppress rar1 for RPM1 function. We constructed the appropriate double mutants 
and noted that both were as susceptible to Pto DC3000(avrRpm1) as rar1 (Fig. 
2.6A). Conductivity measurements of RPM1-mediated HR in these double mutants 
(Fig. 2.6B) gave similar results, supporting the conclusion that neither hsp90.2KO nor 
an hsp90.2-3lra allele can suppress rar1. Thus, the hsp90.2rsp alleles are also 
phenotypically distinct from both a null allele (Fig. 2.6) and the classic ATPase dead 
hsp90.2-3lra (Figs. 2.5 and 2.6). 
 
hsp90.2rsp Alleles Are Not Null Alleles 
Although both hsp90.2rsp alleles encode missense changes, there remained a 
possibility that they are functionally null. If so, then one of the three remaining 
cytosolic HSP90 proteins might compensate for the loss of HSP90.2 in these new 
alleles, as previously noted for hsp90.2KO (Hubert et al. 2003). Arabidopsis has four 
genes encoding cytosolic HSP90, three, including HSP90.2, reside in a cluster. The 




Figure 2.6. Neither an hsp90.2lra allele nor the hsp90.2KO null allele suppress 
rar1.  
(A) Bacterial growth assay measuring disease resistance to Pto DC3000 (avrRpm1) 
mediated by RPM1. Wild-type Col-0 and rar1 mutant plants are compared to hsp90.2-3lra 
rar1 and hsp90.2KO rar1 double mutants.  






We wanted to establish whether stepwise elimination of HSP90 function would 
reveal null phenotypes, which we could then compare to hsp90.2-3lra and hsp90.2-
7rsp alleles. We were unable to recover hsp90.2-5KO hsp90.1KO double mutants. 
However, we did identify plants homozygous for hsp90.1KO and heterozygous for 
hsp90.2-5KO. These were stunted, expressed high accumulation of anthocyanins, 
loss of apical dominance, and very low fecundity. Selfed progeny segregated lethals. 
Hence, HSP90.1 is synthetically lethal with HSP90.2 suggesting that the overall level 
of cytosolic HSP90 has a minimum threshold for viability. Importantly, we were able 
to obtain hsp90.2-3lra hsp90.1KO, hsp90.2-7rsp hsp90.1KO, and hsp90.2-8rsp 
hsp90.1KO double mutants. These were viable and as healthy as either single mutant. 
Hence, hsp90.2-3lra, hsp90.2-7rsp and hsp90.2-8rsp maintained the HSP90 activity 
required to support proper growth and development in the absence of HSP90.1. 
We thus conclude that none of the tested rsp or lra alleles are null for HSP90 activity. 
Our collected genetic data strongly suggest that the hsp90.2rsp alleles are active, 
and that they recapitulate the molecular activity of RAR1 on client NB-LRR 
accumulation. 
 
Analysis of interactions between hsp90.2 mutant variants and RAR1 and SGT1 
Given the correlation between the region of HSP90 mutated in both of our genetic 
screens and the region of HSP90 that physically interacts with RAR1 and SGT1 (see 
Introduction), we were interested in finding out whether our HSP90 mutants were 
affected in their ability to interact with RAR1 and SGT1 in the yeast two-hybrid 
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system. As shown in figure 2.7, wild-type HSP90.2 can interact with both RAR1 and 
SGT1b, but not SGT1a consistent with previously published co-immunoprecipitation 
experiments (Hubert et al. 2003). Hence, this system is likely to accurately reflect in 
vivo interactions in Arabidopsis.  
We found that all four of the hsp90.2lra proteins lost interaction with SGT1b in yeast 
two-hybrid (Fig. 2.7C). Three lost interaction with RAR1 (Fig. 2.7A). The exception 
was S100F (hsp90.2-2lra), previously noted (Hubert et al. 2003) to be partially 
penetrant, which maintained a strong interaction with RAR1. The two rsp mutant 
proteins exhibited opposing RAR1 and SGT1b interactions. The A11T (hsp90.2-7rsp) 
protein maintained strong interactions with both RAR1 and SGT1b. However, the 
R337C (hsp90.2-8rsp) protein lost the ability to interact with both RAR1 and SGT1b. 
None interacted with SGT1a (Fig. 2.7B) indicating that this protein is likely to be 
irrelevant to HSP90.2 function. Western blot analysis showed that all mutant proteins 
were expressed equally well in yeast (Fig. 2.7D). The loss of interaction between 
R337C (hsp90.2-8rsp) and both RAR1 and SGT1b suggests that these interactions 
are not necessary for restoration of NB-LRR function in this allele. This is consistent 
with restoration of several different RAR1- dependent NB-LRR functions in rar1 sgtb 
double mutants (Holt III et al. 2005).  
We were unable to observe an interaction between HSP90.2 and any tested 
fragment of RPM1 by yeast two-hybrid. However, we did see a strong interaction 
between GST-HSP90 fusion purified from E. coli and an HA epitope tagged version 
of RPM1 produced via in vitro transcription and translation in wheat germ lysates 




Figure 2.7. Interactions between hsp90.2 mutant proteins and RAR1 or SGT1b 
does not correlate with phenotype.  
(A-C) β-galactosidase assay quantification of the results of yeast two-hybrid interaction 
measurements between HSP90.2 and mutant variants with (A) RAR1, (B) SGT1a, or (C) 
SGT1b.  
(D) HSP90.2 and mutant variants accumulate to equivalent levels in yeast as measured by 





ability of lra or rsp mutant HSP90.2 proteins to interact with RPM1. Hence, it is 
unlikely that an overall change in NB-LRR protein interaction with HSP90 causes the 
various hsp90.2 mutant phenotypes.  
 
ATPase activity is not predictive of HSP90 activity in NB-LRR function 
All hsp90.2 missense alleles obtained from our two screens were either located in 
the ATPase domain itself, or in the case of R337Crsp, in a part of the middle domain 
physically adjacent to the ATPase domain in the HSP90 crystal structure (Fig. 2.8). 
Thus, differences in ATPase activity associated with the N-terminal HSP90 domain 
(Wandinger et al. 2008) might also explain the different properties of the mutant 
HSP90.2 proteins. We purified recombinant wild-type HSP90.2, and all of the lra and 
rsp variants (Materials and Methods). Circular dichroism analyses of the purified 
proteins showed that all variants had an equivalent proportion of alpha helix and 
beta sheet indicative of proper folding. The ability of these proteins to hydrolyze ATP 
was measured in an ATP regenerating system (Materials and Methods).  
Nearly all of the hsp90.2-8lra alleles are missense changes in amino acids that 
contact bound nucleotide in the crystal structure, and D80N (hsp90.2-3lra; D79N in 
ScHSP90) loses ATP hydrolysis. Hence, it was unsurprising that these proteins 
lacked ATPase activity (Fig. 2.9). R337C (hsp90.2-8rsp) expressed only very weak 
ATPase activity (~2-fold above negative control). Surprisingly, A11T (hsp90.2-7rsp), 
maintained full ATPase activity, but with a ~5-fold increase in the observed KM [wild-




Figure 2.8. All identified AtHSP90.2 mutations in Arabidopsis lie within or near 
the ATPase domain.  
Ribbon structure close-up of the crystal structure of the yeast HSP90 dimer (PDB ID: 2CG9) 
showing the locations of the residues mutated in AtHSP90.2 in red. Individual HSP90 
monomers are shown in light gray and blue. The lra or rsp designation of each respective 
mutant is shown after the residue. ATP is shown in pale yellow. A view of the full dimer is 
shown underneath with the area of the close-up represented box. Axes are shown for 








ATP concentrations are ~3 mM (Stitt et al. 1982), suggesting that the change in KM 
is probably not relevant to the phenotype exhibited by the mutant. Addition of RAR1 
and/or SGT1b to these assays did not alter ATPase activity; this negative result may 
merely mean that we lack other required conditions and / or components for in vitro 
reconstruction.  
N-terminal dimerization is retained in hsp90.2rsp proteins 
Yeast HSP90 functions as a dimer formed via separate N-terminal and C-terminal 
dimerization domains. In yeast, N-terminal dimerization is mediated by a short-N-
terminal stretch of each monomer (Fig. 2.8) and requires ATP binding (Prodromou et 
al. 2000). Using the same assay, we found that dimerization of full-length HSP90.2 
was dependent on the presence of the non-hydrolyzable ATP analogue, AMP-PNP. 
We did not observe HSP90.2 dimers in the absence of AMP-PNP or in the presence 
of ADP. We also tested purified lra and rsp HSP90 mutant proteins for dimerization. 
The lra mutant variants were unable to dimerize in the presence of any tested 
nucleotide (Fig. 2.10A). The rsp mutant variants could dimerize, A11T (hsp90.2-7rsp) 
more than R337C (hsp90.2-8rsp), but both less than wild-type (Fig. 2.10B). Addition 
of RAR1 and/or SGT1b to these assays did not alter dimerization activity under 
these conditions. Hence, ATP binding is required for Arabidopsis HSP90 
dimerization. 
The proportion of HSP90.2 that we observed in the dimerized form was low 
compared to the results reported for yeast HSP90 (Prodromou et al. 2000). It is 




Figure 2.9. HSP90 ATPase activity does not predict hsp90.2 mutant phenotype.  
In vitro ATPase activity of HSP90.2 and mutant variants with a range of ATP concentrations 
was used to determine the Kcat. HSP90 concentration was 5 µM while ATP concentrations 












Arabidopsis HSP90.2. However, this lower proportion of dimer was not due to our 
cross-linking conditions, as increasing the concentration of cross linker nearly 10 fold 
did not result in an increased proportion of dimerized HSP90.2. 
In yeast, an ATP-independent C-terminal domain is sufficient (defined using N-
terminal truncations), but not necessary (defined using C-terminal truncations), for 
HSP90 dimerization (Chen et al. 1998). Given our dimerization results and the 
positions of the rsp mutations on HSP90.2, we wanted to make sure that we were 
assaying the ATP dependent N-terminal activity in our assay. We purified HSP90.2 
containing a short C-terminal truncation, known to abolish ATP-independent 
dimerization in yeast HSP90 (Materials and Methods; (Prodromou et al. 2000). This 
protein was unable to dimerize, even in the presence of AMP- PNP (Fig. 2.11).We 
thus conclude that the C-terminal dimerization domain of Arabidopsis HSP90.2 is 
necessary, but not sufficient (e.g. as in the cases where the N-terminal domain is 
mutated), for dimerization of Arabidopsis HSP90.2 and that the dimerization we 




Figure 2.10. HSP90.2rsp mutant proteins retain dimerization capability. Chemical cross-
linking of wild-type and mutant forms of HSP90.2 in the presence of ADP or the non-
hydrolysable ATP analog AMP-PNP. All variants of HSP90.2 are unable to dimerize in the 
presence of ADP. However, while no lra mutant variants  
(A) are able to dimerize even in the presence of AMP-PNP, both rsp mutant variants.  
(B) can dimerize in the presence of AMP-PNP. The experiment was performed with an 





Figure 2.11. The AtHSP90.2 ATPase domain is insufficient for dimer formation.  
A C-terminal truncation of HSP90 is unable to dimerize in a chemical cross-linking 
experiment. The protein was tested without nucleotide or with 10 mM of the non-
hydrolysable ATP analog, AMP-PNP. The experiment shown was conducted at 0.25 mg/mL 
of HSP90 ΔC and 15 molar equivalents of DMS, similar results were obtained with 30 molar 












We performed two new genetic screens to identify components affecting RPM1-
mediated disease resistance in Arabidopsis. We demonstrate here that two specific 
hsp90.2 mutations suppress rar1 and restore NB-LRR protein accumulation, and 
hence, function. These new hsp90.2rsp alleles demonstrate that HSP90.2 plays a 
broader role in disease resistance in Arabidopsis than previously considered (Hubert 
et al. 2003). The hsp90.2rsp alleles are unique in three ways. (A) The particular 
mutations, A11T and R337C, have not been identified in any genetic screen, 
although the residues are strictly conserved across all eukaryotic species. (B) These 
mutations lead to HSP90 proteins that bypass the requirement for a co-chaperone. 
(C) Most importantly, these mutations result in HSP90 alleles that result in a 
recovery of client protein accumulation and function (Table 2.1). The particular 
features of the hsp90.2rsp alleles, together with emerging structural analyses of 
HSP90 and its co-chaperones, allow us to examine HSP90 function, and propose an 
explicit mechanism for the function of the RAR1 co-chaperone, in NB-LRR protein 
stabilization. 
hsp90.2-7rsp is recessive and encodes an A11T change. hsp90.2-8rsp is weakly semi-
dominant, and encodes a R337C change. Both suppress all known rar1 phenotypes 
to similar degrees. For example, both partially suppress rar1 for RPS5 function, and 
fully suppress rar1 for RPM1 and RPS2 function, as measured by restoration of HR 
and pathogen growth restriction. They also suppress the rar1 enhanced disease 
susceptibility phenotype. Most importantly, both restore accumulation of RPM1-myc 
in rar1. Neither rsp allele has any discernible phenotype in the presence of RAR1. 
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Neither expresses enhanced RPM1 activity in the presence of RAR1. Both provide 
some level of HSP90.2 function, at least as it pertains to viability in the context of a 
decrease in overall HSP90 levels. We used these two new hsp90.2rsp alleles, and 
the four previously identified hsp90lra alleles (Hubert et al. 2003), in a variety of tests 
designed to address how they might differentially influence three properties of 
HSP90: interaction with RAR1 and SGT1b, ATPase activity and HSP90 dimerization. 
The rsp mutant proteins have different properties in these assays, as noted in the 
Results, though both can dimerize to differing degrees. 
The rsp mutations allowed us to examine the relationship between HSP90 ATPase 
activity and HSP90 function. It has long been assumed that ATPase activity is 
required for HSP90 function (Obermann et al. 1998a, Panaretou et al. 1998). The 
data presented here argue against this concept in two ways. First, R337C (hsp90.2-
8rsp) restores NB-LRR accumulation in rar1, yet the R337C mutation exhibits a 
nearly full loss of ATPase activity. Further, R337C is a more efficient suppressor of 
rar1 than A11T based on its semi-dominance, yet it nevertheless has lower ATPase 
activity than A11T. Hence, at least in the absence of RAR1, high ATPase activity is 
not required for NB-LRR accumulation. Second, D80N (hsp90.2-3lra), which is 
unable to bind ATP, does provide some function, to the extent that the hsp90.2-3lra 
hsp90.2-5KO double mutant was viable, and expresses no novel phenotype. In fact, 
given the nearly lethal phenotype observed with a half dose of HSP90.2 in the 
absence of HSP90.1, the D80N mutation must exhibit greater than half the activity of 
wild-type HSP90.2. Although, we leave open the possibility of an entirely different 
explanation for the phenotype of the lra alleles than simple loss of activity. Together 
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these two lines of evidence suggest that HSP90 ATPase activity can be separated 
from HSP90 function as it pertains to the modulation of NB-LRR function.  
Figure 2.12 presents close up views of part of the x-ray structure of nucleotide-
bound yeast HSP90 (Ali et al. 2006). Because HSP90 is so highly conserved across 
kingdoms, the Arabidopsis sequence threads onto this sequence with high 
confidence. The two HSP90 monomers in this structure are held together via an N-
terminal clasp (and at the C-terminus, though that is not relevant here). Each 
monomer of HSP90 contains a 'lid' segment, hinged at residues G95 and G122 (Fig. 
2.12), that swings through nearly 180° from its 'open' position in the ADP bound form 
of HSP90, to a closed ATP-bound conformation. This movement locks in the ATP 
molecule and places the catalytic arginine (371 in Arabidopsis; 380 in yeast) in 
position for interaction with the γ-phosphate of ATP. This movement also facilitates 
formation of the N-terminal dimerization clasp (Ali et al. 2006).  
The structures of nucleotide-bound HSP90 suggest a mechanism for rar1 
suppression by the rsp mutant proteins, and present a clear prediction for RAR1 
function in NB-LRR accumulation. We postulate that A11T and R337C act to favor 
the transition between the ADP- and ATP-bound conformations of HSP90.2, a 
transition characterized by the open-close cycling of the hinged lid. HSP90 has an 5 
fold higher affinity for ADP over ATP (Prodromou et al. 1997). Thus, favoring the 
transition state, perhaps counter-intuitively, favors the ATP bound conformation. The 
HSP90rsp proteins demonstrate that lid conformation is critical for client stabilization. 
Our ATP hydrolysis results suggest that ATP hydrolysis per se is irrelevant to 




Figure 2.12. rsp mutations affect residues in the lid region of HSP90 in the 
closed conformation.  
Ribbon structures of yeast HSP90 (PDB ID: 2CG9) bound to ATP (light gray). This lid (red) 
is hinged at G95 and G122, and swings 180° to fold over the nucleotide-binding pocket 
(yeast G94 and G121).  
(A) R337 (yellow) coordinates interaction of the central ‘client-binding domain’ (purple, left) 
with the flexible lid (red) by interacting with V115 and S116 in the lid region and E363 within 
the middle domain of HSP90 (yeast R346, V114, S115, and E372).  
(B) A11 (yeast A10) from one monomer (green) interacts directly with T96 (yeast T95; red 
side chain) within the hinge of the other monomer. Black arrows in each panel indicate the 





However, it is likely that ATP hydrolysis is part of a regulatory mechanism allowing 
for control of the relative time spent in either conformation. 
In the nucleotide-bound HSP90 structure (Fig. 2.12A), V114 and S115 from the 
closed lid (in red) contact R337 from the same monomer. In R337C (hsp90.2-8rsp), 
these interactions are very likely to be de-stabilized, favoring a lid open conformation, 
consistent with an inability to continue efficient nucleotide cycling. As shown in figure 
2.12B, A11T lies within the N-terminal strand of HSP90. This strand switches from 
an intramolecular interaction in the ADP-bound, lid open, form of HSP90 to an 
intermolecular interaction with the opposing subunit of the HSP90 dimer in the ATP-
bound, lid closed, form (Fig. 2.8). This intermolecular interaction should act to 
maintain and / or strengthen N-terminal dimerization. A11 contacts T96 near the 
base of the hinge on the opposing monomer. Consequently, the A11T mutation 
would be expected to both decrease the binding of the N-terminal strand to the 
opposing monomer, and alter the stability of the ‘lid closed’ conformation. This would 
decrease, but not abolish N-terminal dimerization, as we observed in figure 2.10.  
We propose that de-stabilization of the lid closed conformation by R337C is 
responsible for the diminution of dimerization, loss of interaction with RAR1 (and 
SGT1b) and nearly full loss of ATPase activity. The loss of RAR1 interaction with this 
presumably mis-regulated ‘floppy lid’ does not have ill effects for the function of this 
HSP90 allele as it is, in essence, blind to RAR1 presence or absence. Hence, the 
R337C mechanism of action defines normal RAR1 function; namely, enhancing the 
cycling of the HSP90.2 lid, N-terminal dimerization cycling and client accumulation. 
This proposal is consistent with A11T, where we observed interaction with RAR1 
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(and SGT1b), normal nucleotide hydrolysis, some dimerization, and a recessive 
phenotype (meaning that it is a less efficient rar1 suppressor than the semi-dominant 
R337C). We propose that A11T is also able to bypass normal RAR1 function via its 
less efficient ability to maintain a lid closed conformation.  
Such a model is consistent with recent observations studying the kinetics of N-
terminal dimerization using a FRET-based assay. In these in vitro experiments, two 
conformational states lying between the open and closed conformation were studied 
(Hessling et al. 2009, Mickler et al. 2009). These conformations were shown to be 
rate-limiting steps in the ATPase reaction cycle (Hessling et al. 2009). This same 
paper also showed that the co-chaperone AHA1 is able to bypass one of these 
intermediate states and consequently speed up the rate of ATP hydrolysis. AHA1 
accomplishes this by bypassing the first intermediate state between ATP binding and 
hydrolysis, in favor of the second. Based on this model, we would expect RAR1 (and 
by analogy our rsp alleles) to function by driving the cycle backwards, in effect 
favoring the the first intermediate step. The loss of ATPase activity in the hsp90.2-
8rsp R337C is consistent with this hypothesis, but the normal ATPase activity in the 
hsp90.2-7rsp A11T allele is not. However, the fact that these transition states have 
been shown to be reachable without nucleotide, suggesting only a weak coupling 
between conformational state and ATP hydrolysis (Mickler et al. 2009). Our data 
taken together with these recent reports, further suggest that overall HSP90 function 
and consequent phenotype are much more coupled to the conformational state than 
ATP hydrolysis.  
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These data suggest that NB-LRR proteins are de-stabilized in rar1 because the 
HSP90 lid open-close cycle cannot be properly regulated. This situation is mimicked 
by our hsp90lra alleles, which do not suppress rar1, cannot interact with RAR1 in 
yeast two hybrid, cannot hydrolyze nucleotide or dimerize, and thus have a non-
functional lid open-close cycle. Our overall interpretation is bolstered by the fact that 
RAR1 interacts with the HSP90 ATPase domain in yeast two-hybrid (Takahashi et al. 
2003), and is consistent with a model in which the balanced activities of RAR1 and 
SGT1 on HSP90 determine steady-state NB-LRR protein accumulation and signaling 












   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
Single Amino Acid Changes 
E5R E4R E6R Triticum aestivum  TaHSP90 reduced binding to the CS domain of SGT1 and AtRAR1 
(Kadota et al. 
2008) 
A11T A10T A11T Arabidopsis thaliana Athsp90.2-7 AtHSP90.2 
Restoration of NB-LRR function and 
accumulation in a rar1 mutant; normal 
ATPase activity; normal dimerization; 
normal RAR1 interaction; decreased 
SGT1 interaction 
This Study 
T23I T22I T22I Saccharomyces 
cerevisiae 
 ScHSP82 
Impairs AhR signaling; temperature 
sensitivity; reduced GR activity; 
osmosensitive; increased ATPase 
activity; reduced interaction with 
cdc37; reduced accumulation of GR; 
enhanced AMP-PNP binding; 
enhanced N-terminal dimerization 
(Cox et al. 2004, 
Hawle et al. 2006, 
Millson et al. 2004, 
Nathan et al. 
1995, Peter W. 
Piper 2003, 
Prodromou et al. 
2000) 
T23I T22I T22I Saccharomyces cerevisiae  ScHSC82 
temperature sensitive growth defect; 
reduced GR and v-Src activities; 
enhanced ATPase activity; reduced 
GR accumulation; reduced interactions 
with client protein Sti1 and Sba1 
(Johnson et al. 
2007) 
T23F T22F T22F Saccharomyces cerevisiae  ScHSC82 increases ATP hydrolysis 
(Cunningham et 
al. 2008) 
F24A V23A V23A Saccharomyces cerevisiae  ScHSC82 
4.8 fold reduction of ATP hydrolysis 
(compared with WT) 
(Cunningham et 
al. 2008) 
Y25A Y24A Y24A Saccharomyces cerevisiae  ScHSC82 4.8 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
E292K E301K E292K 
Caenorhabditis 
elegans daf-21(p673) CeHSP90 
defects in specific chemosensory 
responses; reduced fertility 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
E34A E33A E33A Saccharomyces cerevisiae  ScHSP82 decreased ATP hydrolysis 
(Obermann et al. 
1998b, Panaretou 
et al. 1998) 
E34A E33A E33A Saccharomyces cerevisiae  ScHSC82 abolishes ATP hydrolysis 
(Cunningham et 
al. 2008) 
E34A E33A E46A Gallus gallus  HSP90α 
loses the ability to assist HSP70, 
HSP40 and HOP in the refolding 
protein; abolishes ATP hydrolysis 
(Grenert et al. 
1999) 
S36L S37L S38L Drosophila melanogaster E(sev)3A e1D HSP83 
lethality; reduced Raf kinase activity; 
reduced binding to Raf 
(Cutforth et al. 
1994, van der 
Straten et al. 
1997) 
N38A N37A N50A Gallus gallus  HSP90α abolishes nucleotide binding and interacting with p23 
(Grenert et al. 
1999) 
A42V A41V A41V Saccharomyces cerevisiae  ScHSP82 
Impairs AhR signaling; temperature 
sensitivity; reduced GR activity; 
reduced accumulation of GR; 
enhanced AMP-PNP binding; reduced 
ATPase acitivity 
(Cox et al. 2004, 
Nathan et al. 
1995, Prodromou 
et al. 2000) 
A42T A41T A42T Arabidopsis thaliana Athsp90.2-6 AtHSP90.2 
Loss of RPM1 function and 
accumulation; fully penetrant 
phenotype; loss of ATPase activity; 
loss of dimerization; loss of RAR1 
interaction; loss of SGT1 interaction 
This Study 
R47C R46C R48C Drosophila melanogaster 13F3 HSP83 reduced Raf kinase activity 
(van der Straten et 
al. 1997) 
D80N D79N D79N Saccharomyces cerevisiae  ScHSP82 
growth retardation; decreased binding 
to ATP, ADP and p23 
(Obermann et al. 
1998b, Panaretou 
et al. 1998) 
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   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
D80N D79N D79N Saccharomyces cerevisiae  ScHSC82 
reduced interactions with client protein 
Sba1 and Cpr6 
(Johnson et al. 
2007) 
D80N D79N D92A Gallus gallus  HSP90α abolishes nucleotide binding and interacting with p23 
(Grenert et al. 
1999) 
D80N D79N D80N Arabidopsis thaliana Athsp90.2-3 AtHSP90.2 
Loss of RPM1 function and 
accumulation; fully penetrant 
phenotype; loss of ATPase activity; 
loss of dimerization; loss of RAR1 
interaction; loss of SGT1 interaction 
(Hubert et al. 
2003), This Study) 
G82S G81S G81S Saccharomyces cerevisiae  ScHSP82 
Impairs AhR signaling; temperature 
sensitivity; reduced GR activity; 
osmosensitive 
(Cox et al. 2004, 
Nathan et al. 
1995, Peter W. 
Piper 2003) 





temperature sensitivity; impaired 
glucose repression of fbp1(+) 
transcription; suppresses cell cycle 
arrest caused by overexpression of 
wee1 (+); advances mitosis; reduces 
the stability of the client protein Wee1 
(Alaamery et al. 
2008, Aligue et al. 
1994) 
T86E T85E T87E Triticum aestivum  TaHSP90 reduced binding to the CS domain of SGT1 
(Kadota et al. 
2008) 




reduced binding to the CS domain of 
SGT1 
(Kadota et al. 
2008) 
K87E K86E K88E Triticum aestivum  TaHSP90 
reduced binding to the CS domain of 
SGT1; genetically suppresses 
AtSGT1a E223K mutant 
(Kadota et al. 
2008) 
A88E A87E S89E Triticum aestivum  TaHSP90 reduced binding to AtSGT1a (Zhang et al. 2008) 
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   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
D89R E88R D90R Triticum aestivum  TaHSP90 reduced binding to the CS domain of SGT1 and AtRAR1 
(Kadota et al. 
2008) 
V91T I90T V92T Triticum aestivum  TaHSP90 reduced binding to AtSGT1a (Zhang et al. 2008) 
N92R N91R N93R Triticum aestivum  TaHSP90 reduced binding to the CS domain of SGT1 
(Kadota et al. 
2008) 
G95E G94E G95E Arabidopsis thaliana Athsp90.2-1 AtHSP90.2 
Loss of RPM1 function and 
accumulation; fully penetrant 
phenotype; loss of ATPase activity; 
loss of dimerization; loss of RAR1 
interaction; loss of SGT1 interaction 
(Hubert et al. 
2003) This Study) 
A98I A97I A97I Saccharomyces cerevisiae  ScHSP82 
reduced levels of hormone binding by 
the ER (Fliss et al. 2000) 
A98T A97T A97T Saccharomyces cerevisiae  ScHSP82 temperature sensitive 
(Kimura et al. 
1994) 
R99A K98A K106A Homo sapiens  hHSP90 α reduced binding to GA (Onuoha et al. 2007) 
R99E K98E R100E Triticum aestivum  TaHSP90 enhanced binding to the CS domain of SGT1 
(Kadota et al. 
2008) 
S100A S99A S113A Homo sapiens  hHSP90 α abolishes binding to geldanamycin (GA) and ATP (Lee et al. 2004) 
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   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
S100F S99F S100F Arabidopsis thaliana Athsp90.2-2, -4 AtHSP90.2 
Loss of RPM1 function and 
accumulation; partially penetrant 
phenotype; loss of ATPase activity; 
loss of dimerization; normal RAR1 
interaction; loss of SGT1 interaction 
(Hubert et al. 
2003) This Study) 
G101D G100D G113D Gallus gallus  HSP90α does not bind to novobiocin (Marcu et al. 2000) 
T102I T101I T101I Saccharomyces cerevisiae  ScHSP82 
temperature sensitivity; decreases the 
growth rates on media containing 
0.05% maltose; reduced maltose 
induction; shortens the half-life of the 
client protein Mal63p which is a MAL 
activator; reduced levels of hormone 
binding by the estrogen receptor (ER); 
reduced activity of substrate Hap1; 
reduced GR activity; reduced formation 
of CBF3-centromere DNA; 
hypersensitive to GA and RA; 
enhanced interaction with cdc37; 
reduced nucleotide binding; reduced 
ATPase acitivity; diminished N-terminal 
dimerization 
(Bali et al. 2003, 
Fliss et al. 2000, 
Hawle et al. 2006, 
Kimura et al. 
1994, Lee et al. 
2002, Millson et al. 
2004, Nathan et 
al. 1995, Peter W. 
Piper 2003, 
Prodromou et al. 
2000, Stemmann 
et al. 2002, 
Toogun et al. 
2008) 
T102I T101I T101I 
Saccharomyces 
cerevisiae  ScHSC82 
temperature sensitive growth defect; 
reduced GR and v-Src activities; 
reduced ATPase activity; reduced v-
Scr accumulation; reduced interactions 
with Sba1 and Cpr6 
(Johnson et al. 
2007) 
A108N A107N A107N Saccharomyces cerevisiae  ScHSC82 reduced interaction with Sti1 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
A132D A131D A133D Drosophila melanogaster  HSP83 
affected localization of nanos and pgc 
mRNA (Song et al. 2007) 




reduced binding to the CS domain of 
SGT1 
(Kadota et al. 
2008) 
D144R D143R D145R Triticum aestivum  TaHSP90 reduced binding to the CS domain of 
SGT1 and AtRAR1 
(1) 
E145R E144R E146R Triticum aestivum  TaHSP90 reduced binding to the CS domain of SGT1 
(Kadota et al. 
2008) 
G155D G154D G155D Schizosaccharomyces pombe swo1-w1 SpHSP90 
sensitive to stressful growth conditions; 
mitotic defects 
(Alaamery et al. 
2008, Aligue et al. 
1994) 
G171D G170D G170D Saccharomyces cerevisiae  ScHSP82 
temperature sensitivity; abolishes the 
activity  of protein kinase Gcn2; 
increases HSF-dependent gene 
expression; abolishes the high affinity 
ligand binding conformation of human 
androgen receptor (AR); reduced 
levels of hormone binding by the ER; 
decreased activity of p60V-src; reduced 
GR activity at high temperature; 
declines in telomere length; loses p23 
binding and ATPase activity; abolishes 
the accumulation  of Gcn2; reduced 
telomerase DNA binding 
(Cox et al. 2004, 
Donze et al. 1999, 
Duina et al. 1998, 
Fang et al. 1996, 
Fliss et al. 2000, 
Kimura et al. 
1994, Nathan et 
al. 1995, Nathan 
et al. 1997, 
Prodromou et al. 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
K265A K274A K294A Homo sapiens  hHSP90 α 
mimic acetylated; reduced binding to 
cochaperon p23 and client protein 
ErbB2 
(Scroggins et al. 
2007) 
K265Q K274Q K294Q Homo sapiens  hHSP90 α 
mimic acetylated; reduced binding to 
cochaperon p23 and client protein 
ErbB2 
(Scroggins et al. 
2007) 
K265R K274R K294R Homo sapiens  hHSP90 α unacetylated (Scroggins et al. 2007) 
W268G W277G W297G Homo sapiens  hHSP90 α blocks self-oligomerization (Nemoto et al. 2004) 
W291A W300A W296A Saccharomyces cerevisiae  ScHSC82 reduced interaction with Sti1 
(Johnson et al. 
2007) 
W291A W300A W300A 
Saccharomyces 
cerevisiae  ScHSP82 
temperature sensitive growth defect; 
reduced GR activity; enhanced v-Scr 
activity; reduced binding to Aha1; 
increased v-Scr accumulation 
(Hawle et al. 
2006) 
E303K E312K E317K Drosophila melanogaster E(sev)3A e6D HSP83 
lethality; reduced Raf kinase activity; 
affected localization of nanos and pgc 
mRNA; reduced binding to Raf 
(Cutforth et al. 
1994, Song et al. 
2007, van der 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
G304N G313N G313N Saccharomyces cerevisiae  ScHSP82 
Affects all receptor types tested; 
temperature sensitivity; decreased 
growth rates; constitutive expression of 
transcription factor Gcn4; reduced 
levels of hormone binding by the ER; 
reduced activity of substrate Hap1; 
defective pheromone-signaling; 
decreases GR ligand binding activity; 
unstable aporeceptor complexes; 
reduced accumulation of substrate 
proteins Ste7 and Ste11 
(Bohen 1995, 
Bohen et al. 1993)  
G304N G313N G329N Gallus gallus  HSP90α affects interacting with HSP90 
accessory proteins 
(Chen et al. 1998) 
G304S G313S G313S 
Saccharomyces 
cerevisiae  ScHSP82 
Impairs AhR signaling; reduced activity 
of substrate Hap1 and GR; 
temperature sensitivity 
(Cox et al. 2004, 
Lee et al. 2002, 
Nathan et al. 
1995) 
F320A F329A F325A Saccharomyces cerevisiae  ScHSC82 reduced interaction with Sti1 
(Johnson et al. 
2007) 
L334P L343P L338P Schizosaccharomyces pombe git10-201 SpHSP90 
cAMP signaling defect; impaired 
glucose repression of fbp1(+) 
transcription 
(Alaamery et al. 
2008) 
R337C R346C R337C Arabidopsis thaliana Athsp90.2-8 AtHSP90.2 
Restoration of NB-LRR function and 
accumulation in a rar1 mutant; loss of 
ATPase activity; decreased 
dimerization; loss of RAR1 interaction; 
loss of SGT1 interaction 
This Study 
F340A F349A F345A Saccharomyces 
cerevisiae 
 ScHSC82 reduced interaction with Sba1 and 
Cpr6 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
P350A P359A P379A Homo sapiens  hHSP90 α blocks self-oligomerization (Nemoto et al. 2004) 
F355A F364A F384A Homo sapiens  hHSP90 α blocks self-oligomerization (Nemoto et al. 2004) 
E363K E372K E377K Drosophila melanogaster 9J1 HSP83 reduced Raf kinase activity 
(van der Straten et 
al. 1997) 
L367S L376S L392S Gallus gallus  HSP90α reduced binding activity  to p23 (Chadli et al. 2000) 
L367D L376D L372D Saccharomyces cerevisiae  ScHSC82 60 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
I369N L378N L374N Saccharomyces cerevisiae  ScHSC82 3 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
R371A R380A R376A Saccharomyces cerevisiae  ScHSC82 
reduced interaction with Sba1; 6.7 fold 
reduction of ATP hydrolysis 
(Cunningham et 
al. 2008, Johnson 
et al. 2007) 
E372K E381K E381K Saccharomyces cerevisiae  ScHSP82 
Impairs AhR signaling; temperature 
sensitivity; reduced GR activity; 
temperature sensitive growth defect; 
reduced GR and v-Src activities; 
reduced GR and v-Scr accumulations 
(Cox et al. 2004, 
Hawle et al. 2006, 
Nathan et al. 
1995) 
E372K E381K E377K Saccharomyces cerevisiae  ScHSC82 reduced interaction with Sti1 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
E422K E431K E431K Saccharomyces cerevisiae  ScHSP82 
Affects glucocorticoid receptor (GR) 
signaling; Impairs Aryl hydrocarbon 
receptor (AhR) signaling; reduced 
levels of hormone binding by the ER; 
temperature sensitive growth defect; 
reduced v-Src activity; reduced 
ATPase activity; reduced GR 
accumulation 
(Bohen 1995, 
Bohen et al. 1993, 
Cox et al. 2004, 
Fliss et al. 2000, 
Hawle et al. 2006) 
L448A L457A L477A Homo sapiens  hHSP90 α blocks self-oligomerization; blocks binding to HtpGA 
(Matsumoto et al. 
2002) 
S476K S485K S485K Saccharomyces cerevisiae  ScHSP82 
reduced levels of hormone binding by 
the ER (Fliss et al. 2000) 
S476Y S485Y S485Y Saccharomyces cerevisiae  ScHSP82 
temperature sensitive growth defect; 
reduced GR and v-Src activities; 
reduced ATPase activity; reduced 
binding to p23 and AhaI; reduced v-Scr 
accumulation 
(Hawle et al. 2006, 
Kimura et al. 
1994) 
S476Y S485Y S481Y Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
L482S L491S L487S Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
E488A E497E E517A Homo sapiens  hHSP90 α blocks self-oligomerization; blocks 
binding to HtpGA 
(Matsumoto et al. 
2002) 




alters the sexual cycle and partially 
suppresses vegetative incompatibility 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
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ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
T516I T525I T525I Saccharomyces cerevisiae  ScHSP82 
Affects all receptor types tested; 
temperature sensitivity; decreased 
growth rates; constitutive expression of 
transcription factor Gcn4; decreases 
GR ligand binding activity; unstable 
aporeceptor complexes; reduced GR 
and v-Src activities; reduced ATPase 
activity; reduced binding to p23 and 
AhaI; reduced v-Scr accumulation 
(Bohen 1995, 
Bohen et al. 1993, 
Donze et al. 1999, 
Hawle et al. 2006, 
Kimura et al. 
1994) 
T516I T525I T521I Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
T516I T525I T541I Gallus gallus  HSP90α affects interacting with HSP90 accessory proteins (Chen et al. 1998) 
K532Q R540Q M553Q Homo sapiens  hHSP90β moderately enhances dimeric activity (Kobayakawa et al. 2008) 
E537A K545A T566A Homo sapiens  hHSP90 α decreased dimeric activity (Kobayakawa et al. 2008) 
E537T K545T A558T Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et 
al. 2008) 
E537V K545V A558V Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et al. 2008) 
E537I K545I A558I Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et al. 2008) 
E537R K545R A558R Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et 
al. 2008) 
E537Y K545Y A558Y Homo sapiens  hHSP90β moderatenhances dimeric activity (Kobayakawa et al. 2008) 
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S560C S568C S574C Drosophila melanogaster E(sev)3A e3A HSP83 lethality 
(Cutforth et al. 
1994) 
D565T D537T S586T Homo sapiens  hHSP90β moderately enhances dimeric activity (Kobayakawa et al. 2008) 
T578F S586F S592F Drosophila melanogaster E(sev)3A e6A HSP83 
lethality; affected localization of nanos 
and pgc mRNA 
(Cutforth et al. 
1994, Song et al. 
2007) 
A579T A587T A587T Saccharomyces cerevisiae  ScHSP82 
temperature sensitivity; reduced GR 
activity; hypersensitive to GA and RD; 
reduced activity of substrate Hap1 
(Lee et al. 2002, 
Nathan et al. 
1995, Peter W. 
Piper 2003) 
A579T A587T A583T Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
S600A S608M A629M Homo sapiens  hHSP90 α decreased dimeric activity (Kobayakawa et al. 2008) 
S600A S608A M621A Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et al. 2008) 
S600W S608W M621W Homo sapiens  hHSP90β moderately enhances dimeric activity (Kobayakawa et al. 2008) 
S600V S608V M621V Homo sapiens  hHSP90β moderately enhances dimeric activity (Kobayakawa et al. 2008) 
D615A K623A E644A Homo sapiens  hHSP90 α increased chaperon activity (Ramsey et al. 
2000) 
D622A D630A E651A Homo sapiens  hHSP90 α decreased chaperon activity; inhibited binding to Hop 




   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
D624A G632A D653A Homo sapiens  hHSP90 α decreased chaperon activity; abolished binding to Hop 
(Ramsey et al. 
2000) 
L635I K644I V656I Homo sapiens  hHSP90β enhances dimeric activity (Kobayakawa et al. 2008) 
E639A E648A E668A Homo sapiens  hHSP90 α Increased chaperon activity (Ramsey et al. 2000) 
A641F A650F S655F Drosophila melanogaster E(sev)3A e4A HSP83 lethality 
(Cutforth et al. 
1994) 
L649R L658R L654R 
Schizosaccharomyces 
pombe swo1-21 SpHSP90 
temperature sensitive growth defect; 
impaired glucose repression of fbp1(+) 
transcription 
(Alaamery et al. 
2008) 
F655A F664A F660A Saccharomyces 
cerevisiae 
 ScHSC82 reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
E685A E698A E720A Homo sapiens  hHSP90 α abolished binding to PP5 and FKBP52 (Ramsey et al. 2000) 
D687A P700A D722A Homo sapiens  hHSP90 α abolished binding to PP5 and FKBP52 (Ramsey et al. 2000) 
A688A A701A D723A Homo sapiens  hHSP90 α abolished binding to PP5 and FKBP52 (Ramsey et al. 2000) 
D689A D702A D724A Homo sapiens  hHSP90 α abolished binding to PP5 and FKBP52 (Ramsey et al. 2000) 
E696A E706A E729A Homo sapiens  hHSP90 α abolished binding to TPR proteins (Ramsey et al. 2000) 
E697A E707A E730A Homo sapiens  hHSP90 α abolished binding to TPR proteins (Ramsey et al. 2000) 
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   Mutation position 
in reference to 
AtHSP90.2 
Mutation position in 
reference to 
ScHSP90 
Mutation position in 
original organism Species Mutant name Protein Phenotype References 
D699A D709A D732A Homo sapiens  hHSP90 α abolished binding to TPR proteins (Ramsey et al. 2000) 
Changes Involving Two or More Amino Acids 
T23F/R371A T22F/R380A T22F/R376A Saccharomyces cerevisiae  ScHSC82 1.6  fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
F24A/R371A V23A/R380A V23A/R376A 
Saccharomyces 
cerevisiae  ScHSC82 20 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
Y25A/R371A Y24A/R380A Y24A/R376A Saccharomyces cerevisiae  ScHSC82 24 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
S219A/E239A P218A/E249A S226A/S255A Homo sapiens  hHSP90β 
increased transcription activity of AhR 
gene; phosphorylation defect; 
enhanced interaction with AhR; 
reduces the resistance of mouse cell to 
cytochrome c; inhibits phosphorylation; 
enhances binding to client protein 
Apaf-1 
(Kurokawa et al. 
2008, Ogiso et al. 
2004) 
F320A/L322A/F323A F329A/L331A/F332A F329A/L331A/F332A Saccharomyces cerevisiae  ScHSP82 reduced GR and v-Src activities 
(Hawle et al. 
2006) 
R337A/R338A R346A/R347A R362A/R363A Gallus gallus  HSP90α abolishes binding to p23 (Chadli et al. 2000) 
L369N/R371A L378N/R380A L374N/R376A Saccharomyces cerevisiae  ScHSC82 24 fold reduction of ATP hydrolysis 
(Cunningham et 
al. 2008) 
A568T/V571K A576T/R579K A576T/R579K Saccharomyces 
cerevisiae 
 ScHSP82 
Affects all receptor types tested; 
temperature sensitivity; decreased 
growth rates; decreases GR ligand 
binding activity; unstable aporeceptor 
complexes 
(Bohen 1995, 
Bohen et al. 1993) 
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I584A/M585A I592A/M593A I588A/M589A Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
L636S/L637S L645S/L646S L665S/L666S Homo sapiens  hHSP90 α blocks self-oligomerization and binding to client protein 
(Shin-ichi Yamada 
2003) 
L642S/L643S L651S/L652S L647S/L648S Saccharomyces cerevisiae  ScHSC82 
reduced interactions with Sba1 and 
Cpr6 
(Johnson et al. 
2007) 
L642S/L643S L651S/L652S L671S/L672S Homo sapiens  hHSP90 α blocks self-oligomerization and binding to client protein 
(Shin-ichi Yamada 
2003) 
E696A/E697A E706A/E707A E725A/E726A Gallus gallus  HSP90α 
affects interacting with HSP90 
accessory proteins (Chen et al. 1998) 
  Table 2.1. Neither the rsp phenotype nor the rsp alleles mutations have been previously observed.  
This is a comprehensive list of previously-identified HSP90 mutations identified from all organisms in relation to HSP90.2 amino acid 
sequence. Mutations are given in relation to AtHSP90.2 and ScHSP82 sequence and the sequence of the originally-identified 




MATERIALS AND METHODS 
Plant lines 
Transgenic Arabidopsis ecotype Columbia (Col-0; line a11) containing estradiol-
inducible avrRpm1 has been described (Tornero et al. 2002a). For the double RPM1 
screen, we used line a11 plant with an additional transgenic, myc-epitope tagged 
copy of RPM1 introgressed (Tornero et al. 2002b). For the rar1 suppressor screen 
we used the originally isolated rar1-21 mutant identified in line a11 (Tornero et al. 
2002b). For pathology and double mutant analysis, we used rar1-21, rar1-28, or 
hsp90.2-3lra lines with the estradiol-inducible avrRpm1 removed by backcrossing to 
Col-0 and subsequent PCR based marker assisted breeding (Hubert et al. 2003, 
Tornero et al. 2002b). Mutant lines used (all in Col-0 unless noted) were rpm1-3 
(Grant et al. 1995), rps2-101c (Mindrinos et al. 1994), rps5-2 (Warren et al. 1998), 
ecotype Ws-0 as an RPP4 mutant control (van der Biezen et al. 2002), and hsp90.2-
5KO (Hubert et al. 2003). We constructed double mutants of hsp90.2 alleles and rar1-
21 by identifying F2s with a recombination event placing these linked mutations in 
cis. These plants were selfed and resultant F3 individuals were further selected with 
PCR-based markers. hsp90.1KO was produced by selecting a homozygous insertion 
in the SALK T-DNA insertion line 075596 (previously referred to as hsp90.1-2; 
(Takahashi et al. 2003) was identified by molecular analysis of a segregating pool. 
The insertion site was confirmed by sequencing of the T-DNA specific product. 
Pathogen strains, inoculation and growth quantification 
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Pto DC3000 derivatives containing pVSP61 (empty vector), avrPphB, avrRpm1 or 
avrRpt2 have been described (Ritter et al. 1996). Plant inoculations and bacterial 
growth assays were performed as previously described (Tornero et al. 2001). 
Results for all bacterial growth assays represent three replicates with error bars 
representing + / - the standard deviation, a 95% confidence interval. Additionally, all 
assays have been performed independently a minimum of three times with similar 
results. High concentrations of Pto DC3000 (avrRpm1) (OD600=0.1, 5 x 107 cfu/ml) 
were syringe infiltrated into leaves of 4-5 weeks old plants to induce HR. Ion leakage 
assays were carried out as described (Torres et al. 2002).  
Hyaloperonospora arabidopsidis (Hpa) propagation and inoculation were performed 
as described (Holt III et al. 2002). 10-day-old cotyledons of plants were inoculated 
with the asexual spores of Hpa isolate Emwa1. Asexual sporangiophores were 
counted 7 dpi on at least 40 cotyledons for each genotype. Trypan blue staining for 
cell death and the Hp structures was previously described (Koch et al. 1990). 
Pictures of trypan blue stained leaves were taken using a light microscope (Nikon 
Eclipse, Melville, NY).     
 
Identification and map-based cloning of mutations in HSP90.2 
The double RPM1 screen was performed as previously described (Tornero et al. 
2002a). The rar1 suppressor screen was performed using a spray inoculation 
method in which two-week old plants were sprayed with a 10mM MgCl2 suspension 
containing Pto DC3000 (avrPphB) at a concentration of OD600=0.05 (2.5 x 107 cfu/ml) 
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with 0.02% silwet L-77, covered with a clear lid for 4 h, and assessed for chlorosis 
and other symptoms of bacterial infection 4-6 days later. 
Standard genetic crosses and analyses of F1 and F2 progeny were used. From the 
rar1 suppressor screen, rough mapping was performed by crossing rsp rar1-21 
mutants and the Landsberg erecta rar1-10 mutant (Muskett et al. 2002). F2 plants 
were tested for rsp rar1-21-like resistance responses by spray inoculation as 
described above. Resistant F2 individuals were allowed to self and confirmed in the 
F3 generation. DNA from the F2 individuals was used in PCR amplification of known 
PCR-based molecular markers (www.arabidopsis.org) to obtain approximate 
mapping positions. Independent rough mapping of the two mutants showed linkage 
to the same interval. This interval was refined by using molecular markers we 
developed. We used 423 resistant F2 individuals to define a 4.5 Mb interval on the 
bottom arm of chromosome V containing HSP90.2 which is known as a regulator of 
RPM1 stability. By sequencing HSP90.2 in the originally isolated double mutant, a 
G/A transition at position 31 (nucleotide positions relative to the translation start site 
of the published sequence of HSP90.2; At5g56030) was identified in hsp90.2-7rsp. 
The other mutant, rsp2, also contains a mutation (C1423T giving rise to R337C) in 
HSP90.2. 
 
Yeast Two-Hybrid Analysis 
HSP90.2 and mutant derivatives were cloned into pJG4-5 using the EcoRI and XhoI 
restriction sites and site directed mutagenesis via overlap extension. RAR1, SGT1a, 
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and SGT1b were cloned into a GatewayTM compatible version of pEG202, 
pEG202gw (gift of Hiro Kaminaka; (Holt III et al. 2005). Interactions were analyzed in 
yeast strain EGY48. Normal function of the SGT1a construct was shown by testing 
its interaction with RAR1 in the pJG4-5gw vector. Assays were performed using a 
plate reader as described (Serebriiskii et al. 2000) Tecan Group Ltd., GENios, 
Männedorf, Switzerland). Protein levels were analyzed as previously described (Holt 
III et al. 2005). 
 
Protein blot 
For detection of RPM1-myc levels in plants, we introgressed a transgene expressing 
RPM1-myc from the native RPM1 promoter as described (Tornero et al. 2002b). 
Protein extraction and immunodetection from plant tissue were carried out as 
previously described (Hubert et al. 2003).  
 
Production of recombinant proteins 
HSP90.2, mutant variants, and a 110aa C-terminal truncation were cloned into 
pGEX-6p1 as described above and transformed into RIL codon plus cells 
(Strategene). Cells were grown in 2XYT to an OD of approximately 0.4 at 37°C, and 
then the temperature was decreased to 22°C for 45 min, and cells were induced for 
3 h with 1 mM IPTG. Cell pellets were resuspended in buffer A (20 mM Tris pH 8.0, 
300 mM NaCl, and one ‘‘Complete EDTA-Free’’ protease inhibitor tablet (Roche)). 
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After resuspension, cells were lysed using an Avestin Emulsiflex-C5 (Avestin, Inc. 
Ottawa, Canada). The lysates were cleared by centrifugation for 45 min at 15,000 
rpm in an SS-34 rotor. The cleared lysates were run on a 5 mL High Trap 
glutathione column (GE Healthcare) and washed with 10 column volumes of Buffer 
A. The protein was eluted with 5 column volumes Buffer A with 20 mM glutathione. 
50 units/mL PreScission protease (GE Healthcare) was then added to the sample, 
and the protein was cleaved overnight at 4°C while being dialyzed into into Buffer B 
(20 mM sodium phosphate [pH 6.5], 150 mM NaCl, 2 mM DTT). The next morning, 
the protein was loaded onto a HiLoad 16/10 Q sepharose High Performance anion 
exchange column equilibrated in Buffer B and eluted with a 150 to 600 mM linear 
gradient. Fractions were analyzed for purity by SDS-PAGE, and clean fractions were 
pooled and dialyzed into Buffer C (40 mM HEPES, 150 mM KCl, and 5 mM MgCl2 at 
pH 7.5).  
 
Biochemical methods 
Circular dichroism experiments were performed on a Pistar-180 Circular 
Dichroism/Fluorescence spectrophotometer (Applied Photophysics, Ltd, Surrey, 
United Kingdom). Samples at approximately 20 uM were placed in a 0.1-cm cuvette, 
and scans were taken from 195 to 260 nm with 1 nm increments and 30,000 
repetitions per increment.  
ATP hydrolysis assayed were performed as previously described (Panaretou et al. 
1998, Richter et al. 2001). Briefly, 2.5 uM purified HSP90 was incubated with 0.4 
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mM phosphoenol pyruvate, 0.25 mM NADH, and 1% PK/LDH enzyme mix (Sigma). 
Proteins were incubated with multiple concentrations of ATP between 0 and 1.2 mM. 
Experiments were performed in duplicate with a control containing 0.5 mM radicicol 
to measure HSP90 specific activity. Experiments were performed in 200 uL 
reactions in a plate reader (GENios, Tecan Group Ltd., Männedorf, Switzerland) 
Cross-linking experiments were performed as previously described (Prodromou et al. 
2000). 0.25 mg/mL purified HSP90 was incubated for 2 hr with 10mM ADP or AMP-
PNP, after which a 15 molar excess dimethyl suberimidate dihydrochloride (DMS) 
was added for an additional 2 hr incubation. Reactions were stopped by addition of 
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Specific missense alleles of the Arabidopsis Jasmonic Acid co-receptor COI1 
regulate innate immune receptor accumulation and function 
 
PREFACE 
The following chapter was submitted to PLoS Genetics recently. For this paper, I am 
a co-first author with Eui-Hwan Chung. I contributed to paper all the figures and 
tables except Figure 3.9C and 3.11A. Additionally, I wrote the manuscript. Figures 




Plants utilize proteins containing nucleotide binding (NB) and leucine-rich repeat 
(LRR) domains as intracellular innate immune receptors to recognize pathogens and 
initiate a series of defense responses. Since mis-activation of hypersensitive 
response can lead to tissue damage and even developmental arrest, proper 
regulation of NB-LRR protein signaling is critical. RAR1, SGT1, and HSP90 act as 
regulatory chaperones of pre-activation NB-LRR steady-state proteins. We extended 
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our analysis of mutants derived from a rar1 suppressor screen and present two 
allelic rar1 suppressor (rsp) mutations of Arabidopsis COI1. Like all other coi1 
mutations, coi1rsp missense mutations impair Jasmonic Acid (JA) signaling resulting 
in JA-insensitivity. However, unlike previously identified coi1 alleles, both coi1rsp 
alleles lack a male sterile phenotype. The coi1rsp mutants express two sets of 
disease resistance phenotypes. The first, also observed in coi1-1 null allele, includes 
enhanced basal defense against the virulent bacterial pathogen Pto DC3000 and 
enhanced effector-triggered immunity (ETI) mediated by the NB-LRR RPM1 protein 
in both rar1 and wild type backgrounds. Thus, these enhanced disease resistance 
phenotypes depend on the JA signaling function of COI1. Additionally, the coi1rsp 
mutants showed an inability to properly regulate RPM1 levels, exhibiting increased 
RPM1 levels in rar1, but reduced RPM1 levels in RAR1. Importantly, there was no 
change in the steady state RPM1 levels in coi1-1. These results suggest that the 
coi1rsp proteins regulate NB-LRR protein accumulation independent of JA signaling. 
Based on the phenotypic similarities and genetic interactions between coi1rsp and 
hsp90.2rsp mutants, our data suggest that COI1 regulate NB-LRR accumulation via 
two NB-LRR regulators, SGT1b and HSP90. Together, these data demonstrate a 
putative role for COI1 in disease resistance independent of JA signaling and provide 







During their life cycle, plants have to fend off microbial pathogens including fungi, 
bacteria, viruses, and nematodes. To protect themselves, plants rely on the innate 
immune system of each plant cell to detect pathogen attack and subsequently 
activate disease resistance responses. The plant immune system relies on two inter-
related branches. The first branch utilizes pattern recognition receptors (PRRs) to 
identify conserved pathogen associated molecular patterns (PAMPs). This 
recognition then initiates PAMP-triggered immunity (PTI) (Dodds et al. 2010, Jones 
et al. 2006, Maekawa et al. 2011). Although PTI can restrict further colonization in 
some cases, successful pathogens are still able to evade or suppress PTI with their 
effectors (Mudgett 2005). These proteins contribute to pathogen virulence by 
interfering with various plant defense-related cellular processes. However, effectors 
can also be recognized by the intracellular NB-LRR receptor proteins of the plant 
innate immune system (Nimchuk et al. 2003). Recognition of effectors results in 
effector-triggered immunity (ETI) and is the second branch of the plant immune 
system (Dodds et al. 2010, Jones et al. 2006, Maekawa et al. 2011). NB-LRR 
proteins contain a centrally located nucleotide binding site (NB) domain and a C-
terminal leucine-rich repeat (LRR) domain. Mammalian NB-LRR containing (NLR) 
proteins mediate analogous processes in mammalian innate immunity (Ting et al. 
2008). 
NB-LRR-mediated ETI is typically associated with a form of programmed cell death 
at the infection site called the hypersensitive response (HR) (Dodds et al. 2010, 
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Jones et al. 2006, Maekawa et al. 2011). If not controlled, this strong response can 
lead to unnecessary tissue damage. Proper regulation of HR and therefore 
appropriate regulation of pre-activation resting state NB-LRR proteins is critical 
(Belkhadir et al. 2004, Li et al. 2001, Mackey et al. 2002). Genetic analyses 
uncovered three genes, RAR1, SGT1 and HSP90, as key regulators of NB-LRR 
stability and activity (Austin et al. 2002, Azevedo et al. 2002, Hubert et al. 2003, 
Muskett et al. 2002, Shirasu et al. 1999, Takahashi et al. 2003, Tör et al. 2002, 
Tornero et al. 2002, Warren et al. 1999). RAR1, SGT1 and HSP90 proteins can 
interact independently with one another (Azevedo et al. 2002, Hubert et al. 2003, 
Takahashi et al. 2003), and can cooperate as a molecular chaperone complex to 
regulate NB-LRR stability and function. HSP90 is usually thought to be the central 
subunit of the complex (Kadota et al. 2010, Shirasu 2009). RAR1 affects the 
conformational dynamics of HSP90, and modulates the “lid-open” conformation 
required for loading client NB-LRR proteins (Hubert et al. 2009, Zhang et al. 2010). 
However, the functional mechanism which the RAR1-SGT1-HSP90 complex 
maintains NB-LRR levels remains poorly understood. 
As highly conserved proteins, SGT1 and HSP90 also interact with each other in 
mammalian cells, and play essential roles in mammalian immune responses 
mediated by NLR proteins. By co-immunoprecipitation experiments, both SGT1 and 
HSP90 were found to associate with many NLR proteins including NOD1 
(Nucleotide-binding Oligomerization Domain 1), NOD2 (Nucleotide-binding 
Oligomerization Domain 2), and NALP3 (NACHT, LRR and PYD domains-containing 
Protein 3) (da Silva Correia et al. 2007, Mayor et al. 2007). In mammalian cells, 
110 
 
treatment with geldanamycin (GDA), a chemical inhibitor of HSP90, impaired NOD2-
induced NF-κB activity and NALP3-mediated inflammatory responses (Mayor et al. 
2007). Knockdown of HSP90 by RNAi or GDA treatment also reduced the 
accumulation levels of NOD1 and NOD2 (da Silva Correia et al. 2007). These results 
demonstrate that mammalian HSP90 is required for both NLR stability and function. 
In contrast, mammalian SGT1 is only required for NLR functions such as NOD1-
mediated cytokine production, NOD1-mediated cell death, and NALP3-mediated 
inflammatory responses, but not the for NLR stability (da Silva Correia et al. 2007, 
Mayor et al. 2007). Plant SGT1b, however, functions in both NB-LRR activity and 
stability (Holt et al. 2005). Moreover, mammalian SGT1 knockdown reduced the 
association between HSP90 and the NALP3 LRR domain, indicating that 
mammalian SGT1 functions as a co-chaperon of mammalian HSP90 to regulate 
client NLR protein (Mayor et al. 2007). Unlike plant RAR1, CHP1 (CHORD-
containing Protein 1), a homolog of RAR1 in mammals, is not involved in regulating 
NLR protein accumulation or function (Mayor et al. 2007). Taken together, the 
SGT1-HSP90 chaperone complex has functions for mammalian NLR protein stability 
activity, analogous to its functions for plant NB-LRR biology (Kadota et al. 2010, 
Shirasu 2009).  
During infection, both host plants and pathogens regulate phytohormone signaling to 
enhance their defense and virulence respectively. Jasmonic Acid (JA) signaling is a 
well characterized example of phytohormone signaling required for both disease 
resistance and effector-induced susceptibility that is an outcome of suppression of 
PTI (Browse 2009, Nomura et al. 2005). The JA receptor, COI1, acts as the key 
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regulator of JA signaling (Chini et al. 2007, Katsir et al. 2008, Sheard et al. 2010, 
Thines et al. 2007). Mutations in COI1 cause defects in JA responses and 
reproductive development (Feys et al. 1994, Xie et al. 1998). Of note, mutations in 
COI1 also affect, negatively or positively, disease resistance against various plant 
pathogens (Feys et al. 1994, Kloek et al. 2001, Lorenzo et al. 2004, McDowell et al. 
2000, Melotto et al. 2008, Norman-Setterblad et al. 2000, Thatcher et al. 2009, 
Thines et al. 2007, Thomma et al. 1998, Vijayan et al. 1998).  





) E3 ubiquitin ligase complex (Sheard et al. 2010, Xie et al. 1998, Xu et al. 
2002). The function of COI1 is to specifically bind target proteins to promote 
ubiquitination and degradation by the 26S proteasome (Sheard et al. 2010). It is 
therefore assumed that COI1 regulates JA signaling and disease resistance via 
degradation of specific proteins. The connection between JA signaling and SCFCOI1-
mediated protein degradation has been confirmed. The JASMONATE ZIM DOMAIN 
(JAZ) family proteins act as repressors of MYC2, a key transcriptional activator of JA 
responses, by directly interacting with MYC2. JA-Ile, a bioactive JA conjugate, 
induces the degradation of JAZ proteins by enhancing the protein interaction 
between JAZs and COI1, and thus de-represses JA-related transcription activation 
(Chini et al. 2007, Sheard et al. 2010, Thines et al. 2007, Yan et al. 2009). The JAZ 
and MYC proteins also play a role in disease resistance. Overexpression of JAZ1Δ
3A, a C-terminal deletion form of JAZ1, led to enhanced disease resistance against 
Pto DC3000 in Arabidopsis (Thines et al. 2007). The triple mutant for transcription 
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factor genes MYC2, MYC3, and MYC4, which are all repressed by JAZ proteins, 
was as resistant against Pto DC3000 as the coi1 mutant (Fernández-Calvo et al. 
2011). However, the target of SCF
COI1 
in disease resistance responses is still unclear. 
 
In this study, we extend our suppressor screen for new mutants that restore 
impaired RPS5 function in rar1 (Hubert et al. 2009). Here, we describe two novel 
missense alleles of COI1 that suppress the disease resistance phenotypes 
associated with rar1 mutation. Surprisingly, these two coi1 rar1 suppressor (rsp) 
alleles exhibited complete fertility, in contrast to the male sterility associated with all 
other coi1 mutant alleles (Ellis et al. 2002, Xie et al. 1998, Yan et al. 2009). Like 
sgt1b and the hsp90.2rsp alleles, these two coi1rsp alleles interact with rar1 to restore 
the disease resistance responses mediated by some NB-LRRs and the 
accumulation of at least RPM1. Moreover, we demonstrate that overexpression of 
SGT1b can partially inhibit the coi1rsp-enhanced accumulation of RPM1 and RPM1-
mediated disease resistance in rar1. We also observe non-allelic non-
complementation, a rare genetic interaction, between coi1rsp mutants and hsp90.2-
7rsp mutant. These results support the hypothesis that coi1rsp proteins regulate NB-









Identification of new alleles of COI1 and of the rsp3 mutant 
To identify new genes that act with RAR1 to regulate NB-LRR accumulation and 
activation, we performed a suppressor screen for new mutants which can suppress 
the disease susceptibility observed in rar1-21 (a stop mutation in Q52) (Hubert et al. 
2009). Five rar1 suppressor (rsp) mutants were identified from approximately 
200,000 M2 plants from 50 M2 pools that restore resistance responses to both Pto 
DC3000(avrPphB) and Pto DC3000(avrRpm1) (Hubert et al. 2009). Based on map-
based cloning and subsequent allele sequencing, two of the five mutants were found 
to have mutations in COI1 (At2g39940). Following accepted nomenclature 
conventions, we designated these two mutant alleles, coi1-21rsp and coi1-22rsp, 
respectively (Fig. 3.1). Based on disease symptoms after inoculation of Pto 
DC3000(avrRpm1) on backcross F1 and F2 populations, both of the coi1rsp mutants 
were completely recessive (Table 3.1). The coi1-21rsp mutation is a G/A transition 
which leads to a G330E missense change in the COI1 protein. The coi1-22rsp 
mutation is a G/A transition resulting in a G434E missense change in the protein. 
Both mutations are within conserved LRR domains (Fig. 3.1). Using the crystal 
structure of the Arabidopsis COI1 protein, we demonstrated that neither coi1rsp 
mutation is localized in the interfaces of COI1 that make up the ASK1-binding region 
and the ligand-binding pocket (Sheard et al. 2010).  
In addition, another rar1 suppressor (rsp) mutant, which we called rsp3, was isolated 





Figure 3.1. Mutations identified in COI1.  
The F-box domain and the LRR domain are shown in dark and light gray, respectively. The 
allele designation and associated amino acid change is shown in relation to its linear 
position. New alleles introduced in this paper are shown with larger font. 
 
RPM1-mediated resistance in plants 
 Number of plants exhibiting resistance/Total tested 
plants 
coi-21rsp rar1 12/12 
coi-22rsp rar1 12/12 
rar1 0/12 
coi-21rsp rar1 x rar1 F1 0/8 
coi-22rsp rar1 x rar1 F1 0/6 
coi-21rsp rar1 x rar1 F2 31/108 
coi-22rsp rar1 x rar1 F2 26/86 
 




Figure 3.2. rsp3 can suppress all known rar1 phenotypes.  
In addition to two hsp90.2rsp and two coi1rsp mutants, we isolated a fifth mutant, named rsp3 
(rar1 suppressor 3), from the rar1 suppressor screen. Based on disease symptoms after 
inoculation with Pto DC3000(avrRpm1), we determined that rsp3 is dominant. The results of 
bacterial growth experiments showed that the rsp3 mutant suppressed rar1 for disease 
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resistance functions of RPS5 (Fig. 3.2A), RPM1 (Fig. 3.2B) and RPS2 (Fig. 3.2C). rsp3 also 
fully suppressed the decreased basal disease resistance phenotype of rar1 (Fig. 3.2D). In 
addition to disease resistance, RPM1-mediated HR in rar1 was also suppressed by rsp3 
(Fig. 3.2E). We also noted that rsp3 partially suppressed the loss of RPP4 function in rar1 
following infection with Hpa Emwa1 (Fig. 3.2F). Finally, we also found that rsp3 mutant 
suppressed the lowered accumulation of RPM1 in rar1 (Fig. 3.2G). The combined 
phenotypes of rsp3 rar1 mutant demonstrated that rsp3 suppressed, fully or partially, all 
known rar1 phenotypes. Using map-based cloning, we localized rsp3 mutation in a 7 Mbp 
(from 15.9 Mbp to 22.9 Mbp) mapping interval on chromosome I (Fig. 3.2H). No NB-LRR 
regulator has been found in this interval. However, because it is a single dominant allele, 
further characterization of rsp3 is beyond the scope of this paper.  
(A-B) Bacterial growth assays of (A) Pto DC3000(avrPphB), (B) Pto DC3000(avrRpm1), (C) 
Pto DC3000(avrRpt2) and (D) Pto DC3000(EV). Leaves of each indicated genotype were 
dip-inoculated (Tornero et al. 2001).Bacteria were counted at day 0 and day 3. Error bars 
represent 2x SE. 
(E) Conductivity measurements after inoculation with high concentration of Pto 
DC3000(avrRpm1) (5x107 cfu/ml). Error bars represent 2xSE. 
(F) 10-day-old cotyledons were inoculated with Hpa isolate Emwa-1. Asexual 
sprangiophores were quantified 7 days after inoculation on cotyledons for each of the 
indicated genotypes (Holt et al. 2005). (Sp: sprangiophore). 
(G) Western blot analysis of RPM1-myc protein levels in indicated genotypes. Rubisco 
levels stained by Ponceau S serve as loading control. 
(H) The positions of the Simple Sequence Length Polymorphisms (SSLP) markers used for 
rough map-based cloning on chromosome I. rsp3 mutation was localized in the mapping 
interval between marker T27K12(15.9 Mbp) and F19K23(22.9 Mbp). The pathogen growth 
and HR assays were performed independently a minimum of three times with similar results. 





7Mbp region on chromosome I (Fig. 3.2). A mono-allelic, dominant mutation was 
identified in rsp3; its detailed characterization is beyond the scope of this work. 
 
COI1 and HSP90 interact genetically to regulate disease resistance 
We made crosses between hsp90.2-7rsp rar1 and the two coi1rsp rar1 double mutants. 
The disease resistance restoration phenotypes of hsp90.2-7rsp (Hubert et al. 2009) 
and either coi1rsp alleles (Table 3.1) in rar1 are fully recessive with respect to their 
respective wild type phenotypes. F1 plants of crosses between hsp90.2-7rsp and 
either coi1rsp allele were tested for disease symptoms after inoculation of Pto 
DC3000(avrRpm1) (Table 3.2). Surprisingly, both groups of F1 plants displayed 
resistance against Pto DC3000(avrRpm1). In addition, a part of the F2 progenies 
from each F1 were susceptible to Pto DC3000(avrRpm1). These results 
demonstrate non-allelic non-complementation between hsp90.2-7rsp and coi1rsp 
mutants, suggesting that the two proteins function in the same process and likely do 
so in physical proximity (Belanger et al. 1994, Hubert et al. 2003, Larkin et al. 1999).  
 
coi1rsp alleles and coi1-16 partially suppress known rar1 phenotypes 
hsp90.2rsp alleles, which were also isolated from our rar1 suppressor screen, restore 
all known defective NB-LRR functions in a rar1 mutant background (Hubert et al. 
2009). However, a previously published rar1 suppressor mutant, sgt1b, only affected 
a limited number of NB-LRR protein functions (Holt et al. 2005). We therefore tested  
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RPM1-mediated resistance in plants 
 Number of plants exhibiting resistance/Total tested 
plants 
coi-21rsp rar1 12/12 
coi-22rsp rar1 12/12 




















Table 3.2. Non-allelic non-complementation between coi1rsp and hsp90.2rsp 
mutants.  
RPM1-mediated resistance was tested by spray-inoculation with Pto DC3000(avrRpm1). 










both coi1rsp alleles to determine whether they have any NB-LRR specificity in their 
suppression of rar1. As shown in figures 3.3 and 3.4, the coi1rsp alleles partially 
suppress rar1 for RPM1 and RPS5 functions, and fully suppress rar1 for RPS2 
function (Fig. 3.3A, 3.4A, 3.4B). rar1 exhibits enhanced disease susceptibility to the 
virulent bacterial strain Pto DC3000(EV) (Holt et al. 2005, Hubert et al. 2009, 
Tornero et al. 2002). This phenotype might be due to a RAR1 function in basal 
defense, for example an additive effect of lessened accumulation of multiple NB-
LRR proteins (Dodds et al. 2010, Jones et al. 2006, Maekawa et al. 2011). As 
measured by inhibition of bacterial growth, both coi1rsp alleles completely 
suppressed the enhanced disease susceptibility phenotype in rar1 (Fig. 3.3B). 
NB-LRR activation can trigger HR as well as disease resistance responses. RAR1 is 
required for NB-LRR-mediated HR. sgt1b is able to suppress the loss of RPS5-
mediated disease resistance in a rar1 mutant, but not the loss of RPS5-mediated HR 
(Holt et al. 2005). To test if NB-LRR-dependent HR is also restored in coi1rsp rar1 
double mutants, we measured ion leakage as a proxy for HR to quantify RPM1-
mediated HR in plants. Notably, the coi1rsp alleles did not suppress rar1 for impaired 
RPM1-triggered HR (Fig. 3.4C). However, the coi1rsp rar1 plants did restore RPM1-
mediated disease resistance, measured via pathogen growth restriction (Fig. 3.3A).  
RPS5, RPM1 and RPS2 all belong to the CC-NB-LRR subclass. The functions of 
some TIR-NB-LRR proteins also require RAR1. The effect of coi1rsp on TIR-NB-LRR 




Figure 3.3. coi1rsp mutants suppress rar1 phenotypes.  
(A-B) Bacterial growth analysis of (A) Pto DC3000(avrRpm1) and (B) Pto DC3000(EV). 
Bacteria were hand-infiltrated into leaves of each indicated genotype and counted at day 0 
and day 3. Error bars represent 2X SE. Pairwise comparisons for all means for bacterial 
growth on day 3 were performed with One-Way ANOVA test followed by Tukey-Kramer HSD 
at 95% confidence limits.  
(C) Western blot analysis of RPM1-myc levels in the indicated genotypes. RuBisCo levels 
stained by Ponceau S serve as loading controls. The pathogen growth assays and RPM1-




Figure 3.4. coi1rsp alleles suppress some, but not all rar1 phenotypes for NB-
LRR function.  
(A-B) ) Bacterial growth analysis of Pto DC3000(avrPphB) (A) and Pto DC3000(avrRpt2) (B) 
Leaves of indicated genotypes were dip-inoculated (Tornero et al. 2001). Bacteria were 
counted for Day 0 and Day 3. Error bars represent 2X SE. Pairwise comparisons for all 
means for bacterial growth on day 3 were performed with One-Way ANOVA test followed by 
Tukey-Kramer HSD at 95% confidence limits. 
(C) Conductivity measurements after inoculation with high concentration Pto 
DC3000(avrRpm1) (5x107 cfu/ml). Error bars represent 2x SE. 
(D) 10-day-old cotyledons were inoculated with Hpa isolate Emwa1. Asexual 
sprangiophores were quantified 7 days after inoculation on cotyledons for each of the 
indicated genotypes (Holt et al. 2005). (Sp: sprangiophore). The pathogen growth and HR 




(Hpa) isolate Emwa1 to trigger RAR1-dependent RPP4-mediated disease resistance 
(Van Der Biezen et al. 2002). Neither coi1rsp rar1 double mutant inhibited the growth 
of Emwa1 (Fig. 3.4D). This indicates that RPP4 function is not restored in rar1 in the 
presence of either coi1rsp allele. Thus, the coi1rsp alleles possibly suppress rar1 only 
for CC-NB-LRR functions.  
The accumulation of all tested NB-LRR proteins is reduced in rar1 plants, implying 
that the biochemical function of RAR1 is to maintain the stability of NB-LRR proteins 
(Belkhadir et al. 2004, Bieri et al. 2004, Holt et al. 2005, Hubert et al. 2009, Tornero 
et al. 2002). We wondered whether coi1rsp alleles could suppress the decrease of 
NB-LRR protein accumulation in rar1. We introduced our transgenic, myc-tagged 
RPM1 (Boyes et al. 1998) into the coi1rsp rar1 mutants by crossing and marker-
assisted selection. The coi1rsp alleles suppressed the lowered RPM1-myc 
accumulation in rar1, although the re-accumulation of RPM1-myc in coi1rsp rar1 
mutant plants remained lower than in wild type plants (Fig. 3.3C). Hence, the coi1rsp 
alleles partially suppress the biochemical phenotype of rar1.  
The coi1rsp alleles are phenotypically different from two reference alleles, coi1-1 (a 
protein null, encoding W467STOP (Xie et al. 1998). Fig. 3.1) and coi1-16 (encoding 
L245F (Ellis et al. 2002), Fig. 3.1), which are completely or conditionally male sterile. 
We therefore tested whether either coi1-1 or coi1-16 could suppress rar1. Similar to 
the coi1rsp alleles, coi1-1 and coi1-16 enhanced disease resistance responses 
against both Pto DC3000(avrRpm1) and Pto DC3000(EV) in a rar1 background (Fig. 
3.3A, 3.3B). The increase in disease resistance against Pto DC3000(EV) was even 
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higher than that caused by the coi1rsp alleles. To our surprise, coi1-16 resulted in the 
restoration of some RPM1-myc accumulation in rar1, but coi1-1 did not (Fig. 3.3C). 
However, coi1-16 and coi1-1 both allowed restoration of RPM1-mediated disease 
resistance in rar1. Thus, the coi1-16 allele is like the coi1rsp alleles in that all three 
suppress rar1 for both reduced RPM1-myc accumulation and impaired disease 
resistance responses. The “restoration” of disease resistance responses that we 
observed in the coi1-1 rar1 double mutant, by contrast, is not due to restoration of 
NB-LRR protein levels, but rather to bypass suppression of the rar1 disease 
susceptibility phenotypes caused by an as yet unknown mechanism that might be 
related to the antagonistic relationship between JA- and SA-dependent signaling 
(Fig. 3.5A, 3.5B).  
Since the coi1-1 null allele cannot suppress rar1, we suggest that the coi1rsp alleles 
and coi1-16 are recessive gain-of-function alleles for the rar1 suppression 
phenotypes, while they are also loss-of-function alleles for the JA response 
phenotypes as detailed below.  
 
The coi1rsp mutations negatively regulate the accumulation and function of 
NB-LRR proteins in RAR1 
To further study the role of COI1 in regulating RPM1 function, we inoculated coi1rsp, 
coi1-1 and coi1-16 mutant plants with Pto DC3000(avrRpm1) and measured 




Figure 3.5. coi1rsp alleles exhibit enhanced basal defense and additionally 
weakly suppress RPM1 function and accumulation.  
(A-B) Bacterial growth analysis of Pto DC3000(EV) (A) and Pto DC3000(avrRpm1) (B). 
Bacteria were hand-infiltrated into leaves of each indicated genotype and counted at day 0 
and day 3. Error bars represent 2X SE. Pairwise comparisons for all means for bacterial 
growth on day 3 were performed with One-Way ANOVA test followed by Tukey-Kramer HSD 
at 95% confidence limits.  
(C) Conductivity measurements after inoculation with high concentration Pto 
DC3000(avrRpm1) (5x107 cfu/ml). Error bars represent 2x SE. The pathogen growth and HR 
assays were performed independently a minimum of three times with similar results.   
(D) Western blot analysis of RPM1-myc protein levels in indicated genotypes. RuBisCo 
levels stained by Ponceau S serve as loading control. The result displayed is one of three 




wild type. The coi1-1 mutant displayed slightly enhanced resistance compared with 
wild type. We also measured RPM1-mediated HR in these coi1 single mutants using 
the ion leakage assay (Fig. 3.5C). Surprisingly, RPM1-dependent HR was weakened 
in both coi1rsp alleles, demonstrating that the coi1rsp mutations weakly suppress 
RPM1 function. We crossed RPM1-myc into the coi1rsp, coi1-1 and coi1-16 single 
mutants and determined RPM1-myc protein levels in these single mutants (Fig. 
3.5D). The coi1-21rsp and coi1-22rsp mutants both exhibited reduced RPM1-myc 
levels compared to wild type. We conclude from these data that coi1rsp mutations 
regulate RPM1 accumulation and function in both rar1 and RAR1 backgrounds.  
 
Increased RPM1 accumulation in coi1rsp and coi1-16 is post-transcriptionally 
regulated  
Loss of COI1 leads to elevated levels of salicylic acid (SA) in plants (Kloek et al. 
2001), and elevated SA levels can induce the expression of some NB-LRR-encoding 
genes (Kachroo et al. 2003, Shirano et al. 2002, Yang et al. 2004). We measured 
RPM1 mRNA levels in the coi1rsp, coi1-1, and coi1-16 mutant plants by RT-qPCR in 
order to determine whether the increased RPM1-myc levels noted in coi1rsp- and 
coi1-16-were due to an enhanced transcription. Wild type and rar1 plants were used 
as controls. We detected no enhancement of RPM1 mRNA levels among the tested 
coi1 mutants (Fig. 3.6), indicating that the coi1rsp and coi1-16 alleles restore RPM1 




Figure 3.6. coi1rsp and coi1-16 mutations do not enhance RPM1 transcript 
levels.  
RT-qPCR analysis of the expression of RPM1 for indicated genotypes. The result displayed 
is one of three independent RT-qPCRs giving similar results. 
 
The coi1rsp alleles are JA-insensitive  
COI1 has an essential role in JA signaling. All previously isolated COI1 mutations 
caused insensitivity to JA-mediated inhibition of seedling growth (Ellis et al. 2002, 
Xie et al. 1998, Yan et al. 2009). We introduced the coi1rsp alleles into an isogenic 
RAR1 background (see Methods). To observe the effects of JA on the coi1rsp alleles, 
plants were grown in the presence of MeJA, a functional JA derivative (Fig. 3.7A). 
Like coi1-1, the MeJA-treated coi1rsp seedlings grew on MeJA-containing media, 
while the growth of wild type seedlings was severely inhibited. Thus, the coi1rsp 





Figure 3.7. coi1rsp alleles and sgt1b are insensitive to MeJA.  
(A) Seedlings of the indicated genotypes were grown on MS medium (control) or medium 
containing 10 or 50 µM MeJA. 
(B) Inhibition of root elongation by 50 µM MeJA for the indicated genotypes. The root 
elongation assay was performed three times with similar results. At least fifiteen seedlings 




the untreated seedlings, suggesting that the coi1rsp alleles are not as insensitive to 
JA as coi1-1.  
We compared JA-insensitivity phenotypes of the coi1rsp alleles to coi1-1 and coi1-16, 
using a root elongation assay (Fig. 3.8A). Root elongation of all tested seedlings was 
inhibited to some extent by MeJA treatment. The null allele coi1-1 was the most 
insensitive; the root growth of coi1-1 seedlings was only inhibited about 14% by 50 
µM MeJA. Compared with coi1-1, coi1-16 and both coi1rsp alleles displayed 
intermediate insensitivity to MeJA treatment. Their root growth was inhibited about 
27%, 30% and 42% respectively, while the root growth inhibition was more than 60% 
in wild type seedlings.  
JA signaling is important in disease resistance responses. coi1 and other JA 
insensitive mutants exhibit enhanced resistance to the virulent bacterial strain Pto 
DC3000(EV) (Kloek et al. 2001, Melotto et al. 2008, Thines et al. 2007). We 
measured the growth of Pto DC3000(EV) in our coi1rsp alleles, coi1-1, and coi1-16 
(Fig. 3.5A). The coi1rsp alleles also displayed enhanced resistance to Pto 
DC3000(EV), although the increase in the coi1rsp alleles was slightly lower than in 
the reference alleles coi1-1 and coi1-16. 
 
coi1rsp alleles are not null alleles  
The coi1rsp alleles are quantitatively different than the coi1-1 null allele with respect 




Figure 3.8. coi1rsp alleles are insensitive to JA, but are not null alleles.  
(A) Inhibition of root elongation by 50 µM MeJA in at least twenty seedlings of indicated 
genotypes. The root elongation assay was performed independently three times with similar 
results. 
 (B) Western blot analysis of COI1 protein levels in indicated genotypes. COI1 protein was 
marked with asterisk (*). Rubisco levels stained by Ponceau S serve as loading controls. 
Lane order was rearranged, but all potographic adjustments were uniform and performed 
prior to these rearrangements of lane order. The result displayed is one of three 








We noted that COI1 protein accumulation levels in coi1-21rsp, coi1-22rsp and, 
surprisingly, coi1-16 plants greatly decreased compared to wild type and rar1 plants 
(Fig. 3.8B). As expected, no detectable amount of COI1 protein was observed in 
coi1-1. The residual accumulations of COI1 protein confirmed that the coi1rsp alleles, 
and coi1-16, are not COI1 null alleles. 
 
The sgt1b mutant is insensitive to JA responses 
To determine whether other NB-LRR regulators function in regulating JA responses, 
we tested the JA response in the mutants of three NB-LRR co-chaperones, RAR1, 
SGT1b and HSP90.2 by the root elongation assay (Fig. 3.7B). All rar1 and hsp90.2 
mutants were as sensitive to MeJA treatment as wild type, suggesting that neither 
RAR1 nor HSP90.2, plays a role in JA responses. As expected, the sgt1b mutant 
displayed an obvious insensitivity to MeJA (Gray et al. 2003). We also noted MeJA 
insensitivity in the rar1 sgt1b double mutant (Fig. S3B). These results also suggest 
that SGT1b is the only member of RAR1-SGT1-HSP90 NB-LRR co-chaperone 
complex required for JA signaling.  
 
COI1 mutations do not affect the levels of RAR1, SGT1b or HSP90 
accumulation 
coi1 mutations restored the disease resistance responses mediated by three NB-
LRR proteins in rar1 (Fig 3.3A, 3.4A, 3.4B) and thus possibly suppressed rar1 via  
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Figure 3.9. COI1 mutants studied express wild type levels of RAR1, SGT1 and 
HSP90 proteins.  
Western blot analysis of SGT1b, SGT1a, RAR1 and HSP90 protein levels for the indicated 
genotypes. Rubisco levels stained by Ponceau S serve as loading control. The western 








effects upon NB-LRR regulators that control the accumulation, and hence the 
function, of multiple NB-LRR proteins. To examine this possibility, we determined the 
accumulation levels of three NB-LRR regulators, RAR1 (Fig. 3.9A), SGT1b (Fig. 
3.9B), and HSP90 (Fig. 3.9C), in the coi1rsp, coi1-1 and coi1-16 mutants in either 
RAR1 or rar1 backgrounds. These coi1 mutants did not exhibit any dramatic change 
of RAR1, SGT1b or HSP90 protein levels. Therefore, the coi1rsp and coi1-16 alleles 
do not suppress rar1 influencing by regulating the steady state levels of RAR1, 
SGT1b and / or HSP90.   
 
SGT1b antagonizes coi1rsp-mediated RPM1 accumulation and RPM1-
dependent disease resistance in rar1 
The coi1rsp mutants displayed opposite phenotypes: increased NB-LRR 
accumulation and function in rar1 and decreased NB-LRR accumulation and 
function in RAR1. A similar combination of phenotypes was previously observed in 
sgt1b as an rar1 suppressor (Holt et al. 2005). The sgt1b mutation enhanced RPS5 
accumulation and consequent restoration of RPS5-mediated disease resistance in 
rar1, but did not restore RPS5-triggered HR in RAR1 (Holt et al. 2005). This 
similarity implies that coi1rsp mutants might regulate NB-LRR proteins by inhibiting 
the function of SGT1b and hence mimic sgt1b phenotypes.   
Based on this hypothesis, we expected that a high dose of SGT1b would attenuate 
the rar1 suppression phenotypes in the coi1rsp mutants. To test this, we introduced a 
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35S:SGT1b-HA construct into coi1-21rsp rar1 plants containing RPM1-myc. 
Compared with parental coi1-21rsp rar1 plants, T3 plants with higher expression of 
SGT1b::HA exhibited reduced RPM1-myc levels (Fig. 3.10A) and RPM1-mediated 
disease resistance (Fig. 3.10B). However, the RPM1accumulation and RPM1-
mediated disease resistance observed in these T3 plants were still much higher than 
rar1 plants (Fig. 3.10A, 3.10B). These results demonstrated that modest over-
expression of SGT1b can partially inhibit the rar1 suppression phenotypes of coi1rsp 
alleles. As a control, we measured the growth of Pto DC3000(EV) in the plants used 
in the Pto DC3000(avrRpm1) growth assay. No enhanced growth of Pto DC3000(EV) 
was observed in T3 plants (Fig. 3.9C), demonstrating that the reduction of RPM1-
mediated disease resistance in 35S:SGT1b-HA transgenic plants are not due to a 
decrease in basal defense.  
In addition, we measured the HSP90 protein levels and RPM1-myc mRNA levels in 
the transgenic plants used in the western blot analysis. No obvious decrease of 
HSP90 protein level (Fig. 3.11A) or RPM1-myc mRNA level was detected (Fig. 
3.11B), indicating that the reductions of RPM1-myc accumulation in 35S:SGT1b-HA 
transgenic plants are not due to the decrease of HSP90 accumulation or the 






Figure 3.10. SGT1b over-expression antagonizes coi1rsp-dependent RPM1 
accumulation and RPM1-mediated disease resistance in rar1.  
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(A) Western blot analysis of RPM1-myc and SGT1b-HA protein levels in indicated 
genotypes. Rubisco levels stained by Ponceau S serve as loading control. The result 
displayed is one of three independent blots giving similar results.  
(B-C) Bacterial growth analysis of Pto DC3000(avrRpm1) (B) and Pto DC3000(EV)  
(C) Bacteria were hand-infiltrated into leaves of each indicated genotype and counted at day 
0 and day 3. Error bars represent 2X SE. Pair-wise comparisons for all means for bacterial 
growth on day 3 were performed with One-Way ANOVA test followed by Tukey-Kramer HSD 
at 95% confidence limits. The bacterial growth assays were performed independently three 


















Figure 3.11. The reductions of RPM1-myc levels in the 35S:SGT1b-HA 
transgenic plants are not due to the decrease of HSP90 protein level or the 
silencing of RPM1-myc gene.  
(A) Western blot analysis of RPM1-myc, SGT1b, SGT1a, and HSP90 protein levels for the 
indicated genotypes. Rubisco levels stained by Coomassie Brilliant Blue serve as loading 
control;  
(B) RT-Qpcr analysis of the expression of RPM1 and RPM1-myc for the indicated genotypes. 
The western blot and RT-Qpcr assay were performed independently a minimum of two times 







We initially performed a suppressor screen for mutants that could restore the 
diminished NB-LRR RPS5-mediated disease resistance phenotype of rar1 (Hubert 
et al. 2009). These suppressors were isolated in the null rar1-21 background (Fig. 
3.9A), and thus likely represent mutations that either bypass or counteract rar1. We 
reported two novel HSP90 alleles derived from this screen that function to mimic the 
effects of RAR1 on the HSP90 lid open / close cycle required to stabilize NB-LRR 
clients (Hubert et al. 2009). Here, we detail the characterization of two coi1 alleles, 
coi1-21rsp and coi1-22rsp also identified in this screen (Fig. 3.1), and we note that a 
third single allele locus defined by rsp3 has characteristics that suggest it might 
encode another new player in the regulation of NB-LRR accumulation. Because rsp3 
is a single, dominant allele, its description beyond the mutant phenotype was not 
pursued as part of this study. 
The F-box protein COI1 is a core component of the receptor complex for jasmonate 
(JA) (Chini et al. 2007, Sheard et al. 2010, Thines et al. 2007). In plants, mutations 
in COI1 impair all known JA responses and thus result in insensitivity to JA or 
functional JA derivatives (Ellis et al. 2002, Feys et al. 1994, Kloek et al. 2001, Xie et 
al. 1998, Yan et al. 2009). As expected, both of the coi1rsp alleles were JA 
insensitive (Fig. 3.7A, 3.8A). However, the MeJA insensitivity in coi1rsp alleles is 
obviously weaker than in the null allele, coi1-1(Fig. 3.8A).  
In addition to being insensitive to JA, all coi1 alleles identified previously are, at least 
partially, male-sterile (Ellis et al. 2002, Feys et al. 1994, Kloek et al. 2001, Xie et al. 
138 
 
1998, Yan et al. 2009). To our surprise, the two coi1rsp alleles are completely fertile. 
Among the previously described alleles, only coi1-8 (encoding a missense change of 
E543K) exhibits partial fertility in regular growth conditions (Yan et al. 2009). The 
other partially fertile allele, coi1-16 (encoding L245F), is fertile only at low 
temperature (16 degrees C) (Ellis et al. 2002). Similar to the coi1rsp alleles, coi1-8 
exhibited drastically reduced but still detectable COI1 protein levels (Yan et al. 2009). 
A pull-down assay demonstrated that the COI1-8E543K protein retains interaction with 
JAZ1, a substrate of COI1 in SCFCOI1-mediated protein degradation (Yan et al. 2009). 
These results indicate that the weak MeJA insensitivity and intact fertility of the 
coi1rsp mutants are likely due to lower accumulation of functional COI1rsp proteins in 
these mutants. In other words, the coi1rsp mutations, G330E and G434E, cause 
relatively weaker impairments of the COI1 protein stability and activity than the other 
reported coi1 missense alleles.  
 
COI1 functions in both basal defense and ETI 
Mutations in COI1 affect, negatively or positively, disease resistance against various 
plant pathogens (Feys et al. 1994, Kloek et al. 2001, Lorenzo et al. 2004, McDowell 
et al. 2000, Melotto et al. 2008, Norman-Setterblad et al. 2000, Thatcher et al. 2009, 
Thines et al. 2007, Thomma et al. 1998, Vijayan et al. 1998). It is widely accepted 
that the defense phenotypes of coi1 depend on signaling antagonism between SA 
and JA signaling pathways (Kunkel et al. 2002). COI1 mutations disable JA-signaling 
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and consequently enhance SA signaling and SA-induced defense responses by an 
as yet unknown mechanism.  
In Arabidopsis, resistance against the virulent hemi-biotrophic pathogen Pto DC3000 
is a measure of basal defense (Zipfel et al. 2004). In our study, all four tested coi1 
alleles, coi1-21rsp, coi1-22rsp, coi1-1, and coi1-16 displayed enhanced disease 
resistance against Pto DC3000(EV) in both rar1 and RAR1 backgrounds (Fig. 3.3B, 
3.5A). These results correspond to previously published data (Kloek et al. 2001, 
Melotto et al. 2008, Thines et al. 2007), and confirm that COI1 represses basal 
defense, likely via JA-SA antagonism. Besides enhanced basal defense, the coi1 
alleles also displayed enhanced ETI against Pto DC3000(avrRpm1) (Fig. 3.3A, 3.5B). 
Hence, COI1 also inhibits ETI. Since the enhancement of ETI was found in rar1 
mutant plants, RAR1, which is necessary for NB-LRR-mediated ETI in this and many 
other cases, is not required by COI1 to repress ETI.  
 
A plausible mechanism explaining COI1 effects on NB-LRR accumulation in 
rar1 and RAR1 
The four coi1 alleles we analyzed can be classified into three classes based on how 
they influence RPM1-myc levels (Fig. 3.3C, 3.5D). Class I, represented by the null 
allele coi1-1, does not alter RPM1 levels. Class II, represented by coi1-16, enhances 
RPM1 levels in rar1 and has no effect in RAR1. Class III, represented by coi1-21rsp 
and coi1-22rsp, enhance RPM1 levels in rar1, but slightly reduce it in RAR1. Since 
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the null coi1-1 does not show any detectable effect on RPM1 accumulation, the 
enhancement and reduction of RPM1 levels are gain-of-function phenotypes 
conferred by the COI1 mutant proteins accumulating in coi1-16 and the two coi1rsp 
alleles. However, these alleles are all recessive for JA response phenotypes. The 
coexistence of these distinct genetic characteristics demonstrates that coi1-16 and 
coi1rsp alleles are recessive gain-of-function alleles which have lost the JA signaling 
function of COI1, but gained new function, likely via interfering with the activity of 
other protein(s).  
Some publications suggest that the “target” protein with which the recessive gain-of-
function mutation interferes often shares functional redundancy with the mutant 
protein (Dieavart et al. 2003, Hubert et al. 2003, Long et al. 2006, Sijacic et al. 2011, 
Würschum et al. 2006). We found that mutants of two NB-LRR co-chaperones, 
SGT1b and HSP90, have phenotypic similarities with coi1rsp alleles (Holt et al. 2005, 
Hubert et al. 2009, Hubert et al. 2003). These include (Table 3.3): 1) reduced NB-
LRR accumulation in RAR1: RPM1 in hsp90.2lra alleles, RPM1 in coi1rsp alleles; 2) 
enhanced NB-LRR accumulation in rar1: RPM1 in hsp90.2rsp rar1, RPS5 in sgt1b 
rar1, and RPM1 in coi1rsp rar1; 3) impaired NB-LRR-mediated HR in RAR1: RPM1-
mediated HR in hsp90lra, RPS5-mediated HR in sgt1b, and RPM1-mediated HR in 
coi1rsp. COI1 is an F-box protein which is a component of SCF complex. Both 
SGT1b and HSP90 have been reported to associate and function with various SCF 
complexes in plants (Azevedo et al. 2002, Gray et al. 2003, Kim et al. 2011, Liu et al. 
2002). These findings collectively imply that SGT1b and/or HSP90 are likely the 
target proteins of coi1rsp proteins in suppressing rar1.  
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Since the coi1rsp alleles did not affect steady state SGT1b levels (Fig. 3.9), coi1rsp 
alleles might inhibit SGT1b activity to suppress the rar1 phenotype of reduced NB-
LRR accumulation. To test this hypothesis, we overexpressed SGT1b in a coi1-21rsp 
rar1 background. The rar1 suppression phenotypes of coi1-21rsp, including restored 
RPM1-myc accumulation and RPM1-mediated disease resistance, were partially 
complemented by SGT1b overexpression. This result supports our hypothesis, and 
suggests that SGT1 functions with COI1 to regulate NB-LRR accumulation. On the 
other hand, the incomplete complementation could mean that we need higher levels 
of SGT1b over-expression, or that coi1rsp proteins also down-regulate the activity of 
other targets, such as HSP90. This speculation is supported by the non-allelic non-
complementation observed between coi1rsp mutants and hsp90.2-7rsp mutant (Table 
3.2). This specific genetic relationship strongly suggests that COI1 and HSP90 
physically interact with each other or belong to the same protein complex.  
The RAR1-SGT1-HSP90 chaperone complex has been related to the SCF complex 
by two sorts of evidence: 1) SGT1b and HSP90 associate and function with various 
SCF complexes (Azevedo et al. 2002, Gray et al. 2003, Kim et al. 2011, Liu et al. 
2002). RAR1 associates with the COP9 signalosome (CSN) which can inactivate the 
SCF complex (Azevedo et al. 2002, Liu et al. 2002, Lyapina et al. 2001); 2) The 
SCFCPR1 complex negatively regulates the stabilities of two NB-LRR proteins, SNC1 
and RPS2, via the F-box protein CPR1 (Cheng et al. 2011). The SCF component 
SKP1 is required for NB-LRR N protein-mediated resistance response against 
tobacco mosaic virus (TMV) (Liu et al. 2002). This relationship suggests that 
142 
 
                        mutant 
phenotype  coi1
rsp sgt1bedm1 hsp90.2rsp hsp90.2lra 
NB-LRR-mediated 
resistance responses in 
RAR1 



































no phenotype no phenotype 
enhanced RPM1-








accumulation no phenotype 
 
Table 3.3. Phenotypic similarities among coi1, sgt1b, and hsp90.2 mutants. 
(Holt et al. 2005, Hubert et al. 2009, Hubert et al. 2003). rsp: rar1 suppressor; lra: loss of 









RAR1-SGT1-HSP90 chaperone complexes function with an SCF-mediated protein 
degradation pathway to control the accumulation levels of NB-LRR protein and thus 
avoid inappropriate NB-LRR activation (Shirasu 2009). The phenotypes observed in 
our recessive gain-of-function coi1rsp mutants support this hypothesis. The coi1rsp 
mutants suppressed the rar1 mutant for reduced NB-LRR RPM1 accumulation, and 
showed non-allelic non-complementation with hsp90.2. Moreover, overexpression of 
SGT1b partially inhibited the phenotypes of the coi1rsp mutants. Similar to sgt1b and 
hsp90.2rsp mutants, coi1rsp mutants cause reduced NB-LRR protein accumulation 
levels and impaired HR function when moved to a wild type background. The sum of 
these results suggests that the F-box protein COI1 functionally interacts with RAR1-
SGT1-HSP90 chaperone complex and consequently affects NB-LRR protein 
accumulation and function.   
 
MATERIALS AND METHODS 
Plant Lines 
We used coi1-1 (Xie et al. 1998) and coi1-16 (Ellis et al. 2002) as reference alleles. 
For the pathology analyses and root elongation analyses, mutant lines used (all in 
Col-0 background) were rar1-21 (Tornero et al. 2002), rpm1-1 (Grant et al. 1995), 
rps5-2 (Warren et al. 1998), rps2-101c (Mindrinos et al. 1994), sgt1bedm1-1 (Tör et al. 
2002), rar1-21 sgt1bedm1-1 (Holt et al. 2005), hsp90.2-2 (Hubert et al. 2003), hsp90.2-
5KO (Hubert et al. 2003), hsp90.2-7 (Hubert et al. 2009) and hsp90.2-8 (Hubert et al. 
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2009). Ecotype Ws was used as an rpp4 control (Van Der Biezen et al. 2002). We 
constructed coi1-1 rar1-21 and coi1-16 rar-21 double mutants by identifying F2s with 
PCR-based dCAP markers. The F2s with appropriate genotypes were selfed, and 
F3 individuals were further selected with PCR-based dCAP markers. The primers 
and corresponding enzymes for selecting of mutations were:  
coi1-1: 5’-GGC GGT GTA TGT CTC AGA TAT AAC TAA CGA ATC TCT TGA AAG 
C-3’ and 3’-CCT TCA TCT GAT TCA CCT ACG TAA CCC AGC AGA AT-5’ (EcoRI);  
coi1-16: 5’-GAG ATT TTG GAA CTA GTT GGG TTC TTT AAG GCT GCA GCG 
AAT-3’ and 3’- CAG CAA AGT TAA ACG TTT ACC TCG AGA ACT TCC AAA TTA 
GGA C-5’ (HinfI);  
rar1-21: 5’-TCA CGA CGG AAT GAA AGA GTG GAG CTG CTA CTA G-3’ and 3’-
TTT TGG AAC CGA TTT GGC CAG AAC TGG TTT CTC AG-5’ (SpeI); 
coi1-21rsp: 5’- GAC AAC ACT TGT TGT TTT TCT TCA GAC AAG GAA TGT AAC 
CG-3’ and 3’-GGT CGA GTA AGA CAA GGC GGA AGT CAC AGA GGT T-5’ 
(HpaII);  
coi1-22rsp: 5’-CTG TAA GCA GTT GAA GCG GCT GAG GAT TGA A-3’ and 5’-GTC 
TCA GAT AGA ATG CAA ATC GTC TGA GTT TCT TGG AT-5’ (BamHI). 
To make the 35S:SGT1b-HA construct, the coding sequence of SGT1b without its 
stop-codon was amplified by PCR, and then moved into pGWB14 vector (Nakagawa 
et al. 2007). The final destination vector, pGWB14/35S:SGT1b-HA was 
electroporated into the Agrobacterium strain GV3101 for transformation of 
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appropriate genotypes. Transformed plants were selected on MS medium plate 
(PhytoTechnology Laboratories, KS, U.S.) containing Hygromycin B (SIGMA, St. 
Louis, MO, U.S.). The primers for making 35S::SGT1b-HA construct were:  5’-CAC 
CAT GGC CAA GGA ATT AGC AGA GAA AGC TAA AGA AGC T-3’  and 3’-ATA 
CTC CCA CTT CTT GAG CTC CAT GCC ATC TG-5’. 
 
Pathogen Strains, Inoculation, Growth Quantification and Ion Leakage assay 
Pto DC3000 derivatives containing pVSP61(EV), avrRpm1, avrPphB, and avrRpt2 
were maintained as described (Ritter et al. 1996). Plant inoculations and bacterial 
growth assays were performed as described (spray-inoculation (Hubert et al. 2009); 
dip-inoculation (Tornero et al. 2001); infiltrate-inoculation (Holt et al. 2005)). The HR 
test and ion leakage assays were carried out as described (Hubert et al. 2009).  
Hyaloperonospora arabidopsidis (Hpa) isolate Emwa1 was used to inoculated ten-
day-old cotyledons of plants as described (Hubert et al. 2009). Asexual 
sporangiophores were counted 7 days post-inoculation on at least 30 cotyledons for 
each genotype. 
Identification and Map-Based Cloning of Mutations in COI1 
The rar1 suppressor screen was previously described (Hubert et al. 2009). Standard 
genetic analyses and map-based cloning were performed as described (Hubert et al. 
2009). We used 892 disease resistant F2 individuals to define a 60 Kb interval on the 
chromosome II containing COI1. By sequencing COI1 in the originally isolated rar1 
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suppressor mutant, a G/A transition at position 1849 (nucleotide positions relative to 
the translation start site of the published sequence of COI1; AT2G39940) was 
identified in coi1-21rsp. The other mutant, coi1-22rsp, also contains a G/A mutation at 
position 2161 in COI1. To obtain coi1-21rsp and coi1-22rsp single mutants, we 
backcrossed the coi1rsp alleles into an isogenic RAR1 background. PCR-based 
dCAP markers were designed for selecting these two coi1rsp mutations.  
MeJA treatment 
For growth inhibition assays, seedlings were grown on MS medium with different 
concentrations of Methyl Jasmonate (MeJA) (SIGMA) at 22°C under 16 h light/8 h 
dark photoperiod. 10-day-old seedlings were taken picture to show the inhibition 
effects.  
For root elongation assays, seedlings were horizontally grown on MS medium at 
22°C under 24 h light for 4 d. Then seedlings were transferred to new MS medium 
with or without 50 µM MeJA, and grown for additional 4 d. Root elongations during 
these four days were measured.  
Western Blots 
For detection of RPM1-myc in the genotypes mentioned in this study, we introduced 
by crossing and segregation the mutants into plants expressing RPM1-myc from the 
native RPM1 promoter as described (Hubert et al. 2003). The protein extraction and 
western blot were performed as described (Hubert et al. 2003). For detection of 
SGT1b-HA in plants, the protein extraction and western blot were carried out based 
147 
 
on the protocol that was previously used for RPS5-HA (Holt et al. 2005). The anti-
COI1 antiserum was kindly provided by Daoxin Xie (Tsinghua University, Beijing, 
China). The protein extraction and western blot were performed as described (Xu et 
al. 2002). Anti-SGT1 and anti-RAR1 polyclonal antibodies against the full length 
SGT1b and full length RAR1 with C-terminus GST tag were generated in rabbits 
(custom products of Cocalico Biologicals, Inc.). Anti-HSP90-2 was the product of 
Agrisera company (Swedish). For detection of SGT1a, SGT1b, RAR1 and HSP90, 
protein was extracted by the method used for RPM1-myc. Equal loading of protein 
samples was performed by quantifying each sample with Bio-Rad Protein Assay 
(Bio-Rad, Hercules, CA, U.S.). Proteins were separated on 10% SDS-PAGE gel and 
transferred onto Amersham HybondTM-P membranes (GE Healthcare). The blots 
were blocked in TBST (TBS with 0.05% Tween 20) containing 3% nonfat milk for 1 h 
and incubated for an additional 1 h with primary antibody (5000 times (anti-
SGT1)/5000 times (anti-RAR1)/10000 times (anti-HSP90-2) diluted with TBST 
containing 1% nonfat milk) at room temperature. Then the blots were washed for 10 
min two times with 1xTBST and incubated with secondary antibody goat-anti-rabbit 
IgG–HRP (GE Healthcare) (prepared in TBST containing 1% nonfat milk) for 1 h. 
IgG-HRP was detected with ECL Plus Western Blotting Detection System (GE 





Plant RNA was extracted with RNeasy Plant Mini Kit (Qiagen). To eliminate DNA 
contamination, RNA was purified by Turbo DNA FreeTM Kit (Ambion) and RNeasy 
Mini Kit (Qiagen). 2 µg RNA was reverse transcribed with Random Decamers and 
RETROscript kit (Ambion).  
RT-qPCR was performed in a total volume of 25 µl (12.5 µl SYBR Green PCR 
Master Mix (Applied Biosystems), 0.5 µl cDNA, 1 µl Primer 1 (10 µM), 1 µl Primer 2 
(10 µM) and 10 µl H2O) with MJ White 96-well plate and a DNA Engine OPTICONTM 
2 system (MJ Research).  The reaction was run at 95°C for 5 min, followed by 40 
cycles at 95°C for 15 sec, 55°C for 30 sec and 72°C for 30 sec. Dissociation analysis 
was performed after each reaction to confirm the specificity. The relative expression 
of RPM1/RPM1-myc gene in different genotypes was calculated by ΔΔCt method 
(User Bulletin #2, Manual of Applied Biosystems). The primers were newly designed 
or obtained from previous publication (Cao et al. 2008): RPM1/RPM1-myc gene: 5’-
CGC CAT GAG CTT ACC AAA CAG ATT G-3’ and 3’- CAG TGG AAA CTG CTG 
TGA AGT GAG C-5’. The reference gene ELONGATION FACTOR 1 (EF1): 5’-CTG 
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CONCLUSIONS AND FUTURE PROJECTS 
 
 
BACKGROUND AND SIGNIFICANCE 
The nucleotide-binding and leucine-rich repeat (NB-LRR) proteins function as 
immune receptors to recognize pathogens and trigger a series of disease resistance 
responses in plants. The NB-LRR-triggered resistance responses usually include a 
form of programmed cell death at the infection site termed hypersensitive response 
(HR) (Dodds et al. 2010, Jones et al. 2006, Maekawa et al. 2011). Mis-activation of 
this strong response can lead to plant cell death and even developmental arrest 
(Belkhadir et al. 2004, Kim et al. 2010, Li et al. 2001, Li et al. 2010, Mackey et al. 
2003). Hence, proper regulation of NB-LRR protein accumulation levels and pre-
activation resting state are critical to the health of the plant cell.  
 
The work presented in this dissertation focuses on studying three proteins, RAR1 
(REQUIRED FOR MLA12 RESISTANCE 1), SGT1 (SUPPRESSOR OF THE G2 
ALLELE OF SKP1) and HSP90 (HEAT SHOCK PROTEIN 90). All of these proteins 
were identified as key regulators of NB-LRR stability and activation by both genetic 
and biochemical methods. The mutations of these three regulators were observed to
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affect, positively or negatively, the NB-LRR-mediated disease resistance responses 
and/or the accumulation levels of NB-LRR proteins (Austin et al. 2002, Azevedo et al. 
2002, Hubert et al. 2009, Hubert et al. 2003, Muskett et al. 2002, Shirasu et al. 1999, 
Takahashi et al. 2003, Tör et al. 2002, Tornero et al. 2002b). The biochemical 
analyses uncovered RAR1, SGT1 and HSP90 proteins interact with one another: the 
CS domain of SGT1, or the CHORD I domain of RAR1, can interact with the N-
terminal ATPase domain of HSP90; the CHORD II domain of RAR1 also interacts 
with the CS domain of SGT1 (Fig. 4.1a) (Azevedo et al. 2002, Hubert et al. 2003, 
Takahashi et al. 2003). These three proteins cooperate as a molecular chaperone 
complex to regulate the NB-LRR proteins in a signal competent pre-activation state 
(Kadota et al. 2010, Shirasu 2009). Interestingly, animal NB-LRR containing (NLR) 
proteins, which contain similar domains as plant NB-LRR proteins and function as 
animal immune sensors (Ting et al. 2008), are also regulated by animal HSP90 and 
SGT1 (Ye et al. 2008). Since NB-LRRs and NLRs are both regulated by a conserved 
chaperone complex containing HSP90 and SGT1 (Shirasu 2009), studying the role 
of RAR1, SGT1, and HSP90 in plant NB-LRR stabilization and functions can also 
help understand innate immunity in humans and animals. 
Although it has been improved a lot by structural and functional analyses (Kadota et 
al. 2010, Shirasu 2009), the elucidation of the functional mechanism of RAR1- 
SGT1-HSP90 complex still lacked some important details. For instance, is there any 
partner protein required by the chaperone complex to regulate NB-LRR proteins? 
How do those two co-chaperone proteins, RAR1 and SGT1, regulate chaperone 





Fig 1.2. Working Model of RAR1-SGT1-HSP90 chaperone complex.  
(this figure repeatedly appears in the background and significance sections in the 
chapter 4).  
a. RAR1, SGT1 and HSP90 proteins interact with one another. This figure was 
drawn by David Hubert.  
b. The HSP90 cycle. The HSP90 cycle includes several transitions of HSP90 
conformation. Binding of ATP promotes a closed conformation. The lid structure 
swings to lock in the ATP molecule. After ATP hydrolysis, HSP90 adopts an open 
conformation. This figure is drawn, with some changes, after the figures in reference 
(Hartl et al. 2011). 
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c. RAR1 and SGT1 bind to the HSP90 ATPase domain and consequently compete 
for regulating HSP90 conformation. RAR1 is expected to destabilize the lid-closed 
conformation of the HSP90, and induce the lid-open conformation that is important 
for loading NB-LRR clients. This figure is drawn, with some changes, after the 
















NB-LRR proteins? In order to answer these questions, our lab started a rar1 
suppressor screen to identify new components functioning with RAR1 to regulate 
NB-LRR activations and accmulations. I completed this screen and finally isolated 
five rar1 suppressor (rsp) mutants which can suppress the disease susceptibility in a 
rar1 mutant background. Using map-based cloning and subsequent sequencing, 
four of the five rsp mutants were localized in two genes, HSP90.2 and COI1, 
respectively (chapter 2 and 3). These two genes play important roles in plant 
disease resistance. Compared to the hsp90.2 and coi1 mutants identified previously, 
our new hsp90.2rsp and coi1rsp mutants displayed some unique phenotypes.  
Our hsp90.2rsp alleles are uniquely interesting in several ways: 1) The particular 
mutations, A11T and R337C, have not been identified in any previous genetic 
screen, although the residues are strictly conserved across HSP90 proteins from all 
eukaryotic species. In addition, R337C is the first mutation identified in the client-
binding domain of HSP90.2; 2) hsp90.2rsp alleles suppressed all known rar1 
phenotypes, providing a strong genetic evidence that HSP90 and RAR1 function 
together in NB-LRR protein stability and activity; 3) hsp90.2rsp mutations affected 
disease resistance responses mediated by multiple NB-LRR proteins. This 
demonstrated that HSP90.2 plays a broader role in disease resistance in 
Arabidopsis than previously considered (Hubert et al. 2003); 4) Most importantly, 
hsp90.2rsp alleles led to a recovery of client protein accumulation and function, which 
has never been observed in all eukaryotic species. These particular features of  
hsp90.2rsp alleles, together with the structural analyses of HSP90 and its co-
chaperones (Zhang et al. 2010), help us to understand the mechanism how RAR1 
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regulates HSP90 in the RAR1-SGT1-HSP90 chaperone complex. In the RAR1-
SGT1-HSP90 complex, chaperone HSP90 is usually thought to be the central 
subunit. Client NB-LRR proteins rely on HSP90 for stability and/or function. In its N-
terminal ATPase domain, HSP90 contains a lid segment that swings through nearly 
180° from its open position in the ADP-bound form of HSP90, to a closed ATP-
bound conformation (Fig. 4.1b). This movement locks in the ATP molecule places 
the catalytic arginine (371 in Arabidopsis) in position for interaction with the 
phosphate of ATP. This movement also facilitates formation of the HSP90 N-
terminal dimerization clasp (Ali et al. 2006). The amino acid residues mutated in our 
hsp90.2rsp alleles directly interact with the residues in the lid region of HSP90 in the 
closed conformation. A11(A11T in hsp90.2-7rsp) interacts with T96 in the hinge of the 
closed lid region from another HSP90 monomer. R337(R337C in hsp90.2-8rsp) 
interacts with V114 and S115 in the closed lid region from the same HSP90 
monomer. Both hsp90.2rsp mutations, A11T and R337C, are expected to decrease 
the interactions with lid region residues and destabilize the lid close conformation. 
Since the hsp90.2rsp mutations recover, at least partially, all known RAR1 functions 
in a rar1 background, the hsp90.2rsp proteins are considered to functionally replace 
RAR1. Hence, RAR1 is also expected to destabilize the lid-closed conformation of 
the HSP90, and induce the lid-open conformation that is important for loading and/or 
affecting NB-LRR clients (Fig. 4.1c).  
Two other rsp mutations were localized in COI1 gene (chapter 3). Surprisingly, both 
two coi1rsp alleles show complete fertility which is impaired in all previously published 
coi1 mutant alleles (Ellis et al. 2002, Xie et al. 1998, Yan et al. 2009). Since coi1rsp 
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alleles are not protein null, the intact fertility is very likely due to functional COI1rsp 
proteins accumulating in the mutants. In other words, coi1rsp mutations, G330E and 
G434E, cause weaker impairments of COI1 protein stability and activity than other 
coi1 mutations that are sterile. 
COI1 affects disease resistance against various plant pathogens via the antagonism 
between salicylic acid (SA) and JA signaling pathways (Kunkel et al. 2002). 
Mutations in COI1 can block JA-signaling and consequently enhance SA signaling 
and SA-induced defense responses. In this study, I tested coi1rsp alleles and two 
reference alleles, coi1-1 and coi1-16, with the bacterial pathogens Pto DC3000(EV) 
and Pto DC3000(avrRpm1). All four coi1 alleles displayed enhanced resistance 
against both pathogens. These enhancements demonstrate that COI1 and JA 
signaling are not only involved in PAMP-triggered immunity (PTI), but also effector-
triggered immunity (ETI).  
The most interesting phenotypes of coi1rsp alleles are changing the accumulation 
level of the NB-LRR RPM1 protein in a either rar1 or RAR1 genetic backgrounds. In 
a rar1 background, coi1rsp mutations restored the RPM1 protein accumulation. Since 
coi1rsp mutations even slightly decreased RPM1 level in RAR1, the coi1rsp-restored 
RPM1 accumulation is not due to a bypass mechanism. The finding of coi1rsp 
mutants is the first evidence of the direct genetic interaction between COI1 and 
RAR1. In a RAR1 background, coi1rsp mutations slightly reduced RPM1 protein 
levels and RPM1 function. coi1-1 mutation, which is a protein null allele and 
completely loses the COI1-mediated JA signaling (Chini et al. 2007, Thines et al. 
2007), did not show a similar effect on RPM1 accumulation in either rar1 or RAR1. 
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Hence, coi1rsp alleles are gain-of-function alleles which affect RPM1 accumulation in 
a JA-SA crosstalk-independent pattern. Based on the phenotypic similarities, I 
assume that coi1rsp mutations influence the functions of two NB-LRR regulators, 
HSP90 and SGT1b, and consequently alter NB-LRR protein accumulation and 
activation.  
The hsp90.2 and coi1 mutants isolated from our rar1 suppressor screen displayed 
unique phenotypes and helped us identify new functions of the genes which have 
already been well studied. These results suggest that mutant screens, especially 
screen for second-site mutations such as suppressor/enhancer screen, are still a 
powerful tool for us to understand gene functions and interactions.  
 
FUTURE DIRECTIONS 
Identify the mechanism how coi1rsp alleles affect accumulation levels of NB-
LRR proteins 
Much work remains to be done, especially for the work presented in Chapter 3, to 
provide a mechanism model how coi1rsp alleles affect RPM1-myc level in both rar1 
and wild type backgrounds. As mentioned in chapter 3, disabling JA signaling is 
unlikely the mechanism how coi1rsp alleles function on RPM1-myc. COI1rsp proteins 
likely function with two NB-LRR regulators, SGT1b and HSP90, to affect NB-LRR 
proteins. Since COI1 is an F-box protein and functions by binding target protein(s) to 
initiate protein degradation, physical interactions between SGT1b/HSP90 and 
COI1/COI1rsp proteins can be strong evidence supporting the hypothesis that 
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COI1/COI1rsp functions with those two NB-LRR regulators. To detect possible protein 
interactions, I generated 4 Arabidopsis transgenic lines, 35S::COI1::HA coi1-1, 
35S::COI1-21rsp::HA coi1-1, 35S::COI1-22rsp::HA coi1-1 and 35S::COI1-16::HA coi1-
1. The Interactions between native SGT1b/HSP90 proteins and HA tagged proteins 
will be detected by co-immunoprecipitation (co-IP).  
To further study whether and how COI1rsp functions with HSP90, one could cross 
various hsp90.2 mutants including hsp90.2-3lra, hsp90.2-5KO, hsp90.2-7rsp and 
hsp90.2-8rsp into coi1rsp rar1 and coi1rsp rar1 RPM1-myc rpm1-3 background. RPM1-
mediated disease resistance, RPM1-mediated HR and RPM1-myc accumulation will 
be tested in the new mutants and transgenic plants to determinate if any existing 
mutation in HSP90.2 can affect the rar1 suppression phenotypes of coi1rsp mutants.  
 
Map rsp3 mutation 
In addition to two hsp90.2rsp and two coi1rsp mutants, I isolated a fifth mutant, which 
is named rsp3 (rar1 suppressor 3), from the rar1 suppressor screen. Based on 
disease symptoms after inoculation with Pto DC3000(avrRpm1), rsp3 was identified 
as a dominant mutant. Like the studies described in Chapter 2 and Chapter 3, I 
tested rsp3 mutant in a rar1 background by several different assays including 
bacterial growth, RPM1-mediated HR, Hpa Emwa1 growth, and RPM1-myc 
accumulation. The results of my tests demonstrated that rsp3 mutant suppressed, 
fully or partially, all known rar1 phenotypes (Fig. 3.2). As all the suppressions were 
observed in rar1-21 which completely lacks RAR1 protein, rsp3 mutant likely 
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counteracts the phenotypes of rar1 by up-regulating all the RAR1-dependent 
signaling pathways, but not enhancing the activity of RAR1 protein. Using map-
based cloning, I localized rsp3 mutation in a 7 Mbp (from 15.9 Mbp to 22.9 Mbp) 
mapping interval on chromosome I (Fig. 3.2h).  No NB-LRR regulator has been 
found in this interval.  
To follow up on my preliminary findings, one could keep narrowing down this interval 
to make it as small as possible, and then sequence the entire interval to find 
possible rsp3 mutation. Since rsp3 mutant is dominant and only has one allele, extra 
genetic tests will be required to confirm the mutation identified by sequencing is 
responsible for the rsp3 phenotypes. Every possible mutated gene and its own 
promoter will be cloned and transformed into rar1 mutant plants. If its expression 
suppresses the rar1 phenotypes, a mutated gene will be determined to contain rsp3 
mutation.  
 
Double RPS5 screen 
To find more components that function with RAR1 and SGT1 in regulating NB-LRR 
protein accumulation, I started up a new forward genetic screen. This screen is 
based on our previously published demonstration that SGT1b antagonizes RAR1 to 
control RPS5-mediated disease resistance (Holt et al. 2005). We plan to isolate 
suppressors of the rar1 sgt1 phenotype after infection with bacterial pathogen Pto 
DC3000(avrPphB), which triggers RPS5 function. The strategy of this screen has 
two advantages: (1) The new genes identified in the screen are very likely involved 
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in the same biological process as the RAR1 and/or SGT1b; (2) sgt1b can suppress 
rar1 for restoration of RPS5 accumulation and function, but not RPM1 or RPS2. This 
suggests that RPS5 might require a suite of components that may not entirely 
overlap with other NB-LRR proteins like RPM1. The screen might identify these 
components.  
In our previous forward genetics screens for mutants that cannot recognize RPM1-
recoganized effector AvrRpm1, the most obvious problems encountered was that 
more than ninety alleles of rpm1 mutant were identified due to the large size of 
RPM1 (Tornero et al. 2002a). In order to eliminate the repeated isolation of new 
loss-of-function mutations in RPS5 in new screen, I applied plants containing an 
additional, transgenic copy of RPS5. Since these plants have two functional copies 
of RPS5, the possibility of isolation new rps5 alleles should be greatly reduced. To 
detect the accumulation of RPS5 in future mutants, the additional, transgenic copy of 
RPS5 used in the new screen is the translational fusion to the HA-epitope. Thus, the 
genotype of plants used in the new suppressor screen is Col-0 ecotype rar1-21 
sgt1b1-1 double mutant plants containing both wild type endogenous copy of RPS5 
and an additional transgenic copy of RPS5-HA. This new screen is thus named 
“double RPS5 screen”. So far, tens of independent transgenic lines, which express 
RPS5-HA in rar1 sgt1b background, have been isolated. As measured by inhibition 
of Pto DC3000(avrPphB) growth, three lines were identified to be as resistant 
against bacteria as rar1 sgt1b mutant. These lines are used as parental lines in the 
screen. From this screen, we expect to obtain: 1) New genes required for RPS5 
function. To identify the mutations of this class, one could map single mutant alleles 
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by a cross to La-er rar1-10 sgt1-3 double mutant containing a transgenic copy of 
RPS5-HA which can offer RPS5 function in La-er background (La-er lacks a 
functional copy of RPS5); 2) Mutations in PBS1 and PBS3. The pbs1 and pbs3 
mutants were identified previously in a screen for Arabidopsis mutants exhibiting 
enhanced susceptibility to the Pto DC3000(avrPphB) (Warren et al. 1999). It is 
expectable that mutations in PBS1 or PBS3 might also suppress of RPS5-mediated 
resistance responses in rar1 sgt1b background; 3) Mutations in NDR1. Given NDR1 
is required for the RPS5-meidated resistance to Pto DC3000(avrPphB) (Tornero et 
al. 2002b), NDR1 will be sequenced in all putative mutants; 4) Mutations in HSP90. 
There are several cases in which HSP90, RAR1 and SGT1b have been shown to 
function together. First, HSP90 protein has been shown to associate with RAR1 and 
SGT1b in Arabidopsis; Second, the hsp90.2ATPase
 
mutant acts synthetically with a 
sgt1b mutant, as the double mutant is susceptible to Pto DC3000(avrRpt2) 
(unpublished data, David Hubert); Third, hsp90.2rsp mutants can suppress of all 
known rar1 phenotypes. The possible new alleles of hsp90 mutants might be helpful 
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